Skip to main content
Top
Published in: Molecular Neurodegeneration 1/2009

Open Access 01-12-2009 | Review

Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle

Authors: Kristen A Malkus, Elpida Tsika, Harry Ischiropoulos

Published in: Molecular Neurodegeneration | Issue 1/2009

Login to get access

Abstract

While numerous hypotheses have been proposed to explain the molecular mechanisms underlying the pathogenesis of neurodegenerative diseases, the theory of oxidative stress has received considerable support. Although many correlations have been established and encouraging evidence has been obtained, conclusive proof of causation for the oxidative stress hypothesis is lacking and potential cures have not emerged. Therefore it is likely that other factors, possibly in coordination with oxidative stress, contribute to neuron death. Using Parkinson's disease (PD) as the paradigm, this review explores the hypothesis that oxidative modifications, mitochondrial functional disruption, and impairment of protein degradation constitute three interrelated molecular pathways that execute neuron death. These intertwined events are the consequence of environmental exposure, genetic factors, and endogenous risks and constitute a "Bermuda triangle" that may be considered the underlying cause of neurodegenerative pathogenesis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Merlini G, Bellotti V: Molecular mechanisms of amyloidosis. N Engl J Med. 2003, 349: 583-596. 10.1056/NEJMra023144.PubMed Merlini G, Bellotti V: Molecular mechanisms of amyloidosis. N Engl J Med. 2003, 349: 583-596. 10.1056/NEJMra023144.PubMed
2.
go back to reference Jenner P, Olanow CW: Oxidative stress and the pathogenesis of Parkinson's disease. Neurology. 1996, 47: S161-S170.PubMed Jenner P, Olanow CW: Oxidative stress and the pathogenesis of Parkinson's disease. Neurology. 1996, 47: S161-S170.PubMed
3.
go back to reference Storch A, Jost WH, Vieregge P, Spiegel J, Greulich W, Durner J, Muller T, Kupsch A, Henningsen H, Oertel WH, Fuchs G, Kuhn W, Niklowitz P, Koch R, Herting B, Reichmann H, German Coenzyme, QSG: Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch Neurol. 2007, 64 (7): 938-944. 10.1001/archneur.64.7.nct60005.PubMed Storch A, Jost WH, Vieregge P, Spiegel J, Greulich W, Durner J, Muller T, Kupsch A, Henningsen H, Oertel WH, Fuchs G, Kuhn W, Niklowitz P, Koch R, Herting B, Reichmann H, German Coenzyme, QSG: Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch Neurol. 2007, 64 (7): 938-944. 10.1001/archneur.64.7.nct60005.PubMed
4.
go back to reference Bandhyopadhyay U, Cuervo AM: Chaperone-mediated autophagy in aging and neurodegeneration: lessons from alpha-synuclein. Exp Geront. 2007, 42: 120-128. 10.1016/j.exger.2006.05.019. Bandhyopadhyay U, Cuervo AM: Chaperone-mediated autophagy in aging and neurodegeneration: lessons from alpha-synuclein. Exp Geront. 2007, 42: 120-128. 10.1016/j.exger.2006.05.019.
5.
go back to reference Rubinsztein DC: The roles of intracellular protein-degradation pathways in neurodegeneration. Nature. 2006, 443: 780-786. 10.1038/nature05291.PubMed Rubinsztein DC: The roles of intracellular protein-degradation pathways in neurodegeneration. Nature. 2006, 443: 780-786. 10.1038/nature05291.PubMed
6.
go back to reference Keller JN, Dimayuga E, Chen Q, Thorpe J, Gee J, Ding Q: Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int J Biochem Cell Biol. 2004, 36: 2376-2391. 10.1016/j.biocel.2004.05.003.PubMed Keller JN, Dimayuga E, Chen Q, Thorpe J, Gee J, Ding Q: Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int J Biochem Cell Biol. 2004, 36: 2376-2391. 10.1016/j.biocel.2004.05.003.PubMed
7.
go back to reference Ross CA, Pickart CM: The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases. Trends Cell Biol. 2004, 14: 703-711. 10.1016/j.tcb.2004.10.006.PubMed Ross CA, Pickart CM: The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases. Trends Cell Biol. 2004, 14: 703-711. 10.1016/j.tcb.2004.10.006.PubMed
8.
go back to reference McNaught KSP, Perl DP, Brownell A-L, Olanow CW: Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol. 2004, 56: 149-162. 10.1002/ana.20186.PubMed McNaught KSP, Perl DP, Brownell A-L, Olanow CW: Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol. 2004, 56: 149-162. 10.1002/ana.20186.PubMed
9.
go back to reference Zeng B-Y, Bukhatwa S, Hikima A, Rose S, Jenner P: Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats. Ann Neurol. 2006, 60: 248-252. 10.1002/ana.20932.PubMed Zeng B-Y, Bukhatwa S, Hikima A, Rose S, Jenner P: Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats. Ann Neurol. 2006, 60: 248-252. 10.1002/ana.20932.PubMed
10.
go back to reference Schapira AHV, Cleeter MWJ, Muddle JR, Workman JM, Cooper JM, King RHM: Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons. Ann Neurol. 2006, 60: 253-255. 10.1002/ana.20934.PubMed Schapira AHV, Cleeter MWJ, Muddle JR, Workman JM, Cooper JM, King RHM: Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons. Ann Neurol. 2006, 60: 253-255. 10.1002/ana.20934.PubMed
11.
go back to reference Manning-Bog A, Reaney SH, Chou VP, Johnston LC, McCormack AL, Johnston J, Langston JW, Monte DAD: Lack of nigrostriatal pathology in a rat model of proteasome inhibition. Ann Neurol. 2006, 60: 256-260. 10.1002/ana.20938.PubMed Manning-Bog A, Reaney SH, Chou VP, Johnston LC, McCormack AL, Johnston J, Langston JW, Monte DAD: Lack of nigrostriatal pathology in a rat model of proteasome inhibition. Ann Neurol. 2006, 60: 256-260. 10.1002/ana.20938.PubMed
12.
go back to reference Bove J, Zhou C, Jackson-Lewis V, Taylor J, Chu Y, Rideout HJ, Wu D-C, Kordower JH, Petrucelli L, Przedborski S: Proteasome inhibition and Parkinson's disease modeling. Ann Neurol. 2006, 60: 260-264. 10.1002/ana.20937.PubMed Bove J, Zhou C, Jackson-Lewis V, Taylor J, Chu Y, Rideout HJ, Wu D-C, Kordower JH, Petrucelli L, Przedborski S: Proteasome inhibition and Parkinson's disease modeling. Ann Neurol. 2006, 60: 260-264. 10.1002/ana.20937.PubMed
13.
go back to reference Kordower JH, Kanaan NM, Chu Y, Babu RS, III JS, Terpstra BT, Sortwell CE, Steece-Collier K, Collier TJ: Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys. Ann Neurol. 2006, 60: 264-268. 10.1002/ana.20935.PubMed Kordower JH, Kanaan NM, Chu Y, Babu RS, III JS, Terpstra BT, Sortwell CE, Steece-Collier K, Collier TJ: Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys. Ann Neurol. 2006, 60: 264-268. 10.1002/ana.20935.PubMed
14.
go back to reference Massey A, Kiffin R, Cuervo AM: Pathophysiology of chaperone-mediated autophagy. Int J Biochem Cell Biol. 2004, 36: 2420-2434. 10.1016/j.biocel.2004.04.010.PubMed Massey A, Kiffin R, Cuervo AM: Pathophysiology of chaperone-mediated autophagy. Int J Biochem Cell Biol. 2004, 36: 2420-2434. 10.1016/j.biocel.2004.04.010.PubMed
15.
go back to reference Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y: Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol. 1997, 12 (1): 25-31.PubMed Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y: Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol. 1997, 12 (1): 25-31.PubMed
16.
go back to reference Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, Cuervo AM: Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol. 2005, 64 (2): 113-122.PubMed Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, Cuervo AM: Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol. 2005, 64 (2): 113-122.PubMed
17.
go back to reference Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, DiFiglia M: Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol. 1997, 42: 604-612. 10.1002/ana.410420411.PubMed Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, DiFiglia M: Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol. 1997, 42: 604-612. 10.1002/ana.410420411.PubMed
18.
go back to reference Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, Nixon RA: Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci. 1996, 16 (1): 186-199.PubMed Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, Nixon RA: Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci. 1996, 16 (1): 186-199.PubMed
19.
go back to reference Hornung J, Koppel H, Clarke P: Endocytosis and autophagy in dying neurons: an ultrastructural study in chick embryos. J Comp Neurol. 1989, 283: 425-437. 10.1002/cne.902830310.PubMed Hornung J, Koppel H, Clarke P: Endocytosis and autophagy in dying neurons: an ultrastructural study in chick embryos. J Comp Neurol. 1989, 283: 425-437. 10.1002/cne.902830310.PubMed
20.
go back to reference Xue L, Fletcher GC, Tolkovsky AM: Autophagy Is Activated by Apoptotic Signalling in Sympathetic Neurons: An Alternative Mechanism of Death Execution. Molecular and Cellular Neuroscience. 1999, 14: 180-198. 10.1006/mcne.1999.0780.PubMed Xue L, Fletcher GC, Tolkovsky AM: Autophagy Is Activated by Apoptotic Signalling in Sympathetic Neurons: An Alternative Mechanism of Death Execution. Molecular and Cellular Neuroscience. 1999, 14: 180-198. 10.1006/mcne.1999.0780.PubMed
21.
go back to reference Yue Z, Horton A, Bravin M, DeJager PL, Selimi F, Heintz N: A Novel Protein Complex Linking the [delta]2 Glutamate Receptor and Autophagy: Implications for Neurodegeneration in Lurcher Mice. Neuron. 2002, 35: 921-933. 10.1016/S0896-6273(02)00861-9.PubMed Yue Z, Horton A, Bravin M, DeJager PL, Selimi F, Heintz N: A Novel Protein Complex Linking the [delta]2 Glutamate Receptor and Autophagy: Implications for Neurodegeneration in Lurcher Mice. Neuron. 2002, 35: 921-933. 10.1016/S0896-6273(02)00861-9.PubMed
22.
go back to reference Borsello T, Croquelois K, Hornung J-P, Clarke PGH: N-methyl-d-aspartate-triggered neuronal death in organotypic hippocampal cultures is endocytic, autophagic and mediated by the c-Jun N-terminal kinase pathway. Eur J Neurosci. 2003, 18: 473-485. 10.1046/j.1460-9568.2003.02757.x.PubMed Borsello T, Croquelois K, Hornung J-P, Clarke PGH: N-methyl-d-aspartate-triggered neuronal death in organotypic hippocampal cultures is endocytic, autophagic and mediated by the c-Jun N-terminal kinase pathway. Eur J Neurosci. 2003, 18: 473-485. 10.1046/j.1460-9568.2003.02757.x.PubMed
23.
go back to reference Yu L-Y, Jokitalo E, Sun Y-F, Mehlen P, Lindholm D, Saarma M, Arumae U: GDNF-deprived sympathetic neurons die via a novel nonmitochondrial pathway. J Cell Biol. 2003, 163: 987-997. 10.1083/jcb.200305083.PubMedCentralPubMed Yu L-Y, Jokitalo E, Sun Y-F, Mehlen P, Lindholm D, Saarma M, Arumae U: GDNF-deprived sympathetic neurons die via a novel nonmitochondrial pathway. J Cell Biol. 2003, 163: 987-997. 10.1083/jcb.200305083.PubMedCentralPubMed
24.
go back to reference Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, Baehrecke EH, Lenardo MJ: Regulation of an ATG7-beclin 1 Program of Autophagic Cell Death by Caspase-8. Science. 2004, 304: 1500-1502. 10.1126/science.1096645.PubMed Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, Baehrecke EH, Lenardo MJ: Regulation of an ATG7-beclin 1 Program of Autophagic Cell Death by Caspase-8. Science. 2004, 304: 1500-1502. 10.1126/science.1096645.PubMed
25.
go back to reference Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB, Tsujimoto Y: Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol. 2004, 6: 1221-1228. 10.1038/ncb1192.PubMed Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB, Tsujimoto Y: Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol. 2004, 6: 1221-1228. 10.1038/ncb1192.PubMed
26.
go back to reference Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, Mizushima N: Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006, 441: 885-889. 10.1038/nature04724.PubMed Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, Mizushima N: Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006, 441: 885-889. 10.1038/nature04724.PubMed
27.
go back to reference Komatsu M, Waguri S, Chiba T, Murata S, Iwata J-i, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K: Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006, 441: 880-884. 10.1038/nature04723.PubMed Komatsu M, Waguri S, Chiba T, Murata S, Iwata J-i, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K: Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006, 441: 880-884. 10.1038/nature04723.PubMed
28.
go back to reference Qin Z-H, Wang Y, Kegel KB, Kazantsev A, Apostol BL, Thompson LM, Yoder J, Aronin N, DiFiglia M: Autophagy regulates the processing of amino terminal huntingtin fragments. Hum Mol Genet. 2003, 12: 3231-3244. 10.1093/hmg/ddg346.PubMed Qin Z-H, Wang Y, Kegel KB, Kazantsev A, Apostol BL, Thompson LM, Yoder J, Aronin N, DiFiglia M: Autophagy regulates the processing of amino terminal huntingtin fragments. Hum Mol Genet. 2003, 12: 3231-3244. 10.1093/hmg/ddg346.PubMed
29.
go back to reference Ravikumar B, Duden R, Rubinsztein DC: Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet. 2002, 11: 1107-1117. 10.1093/hmg/11.9.1107.PubMed Ravikumar B, Duden R, Rubinsztein DC: Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet. 2002, 11: 1107-1117. 10.1093/hmg/11.9.1107.PubMed
30.
go back to reference Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC: {alpha}-Synuclein Is Degraded by Both Autophagy and the Proteasome. J Biol Chem. 2003, 278: 25009-25013. 10.1074/jbc.M300227200.PubMed Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC: {alpha}-Synuclein Is Degraded by Both Autophagy and the Proteasome. J Biol Chem. 2003, 278: 25009-25013. 10.1074/jbc.M300227200.PubMed
31.
go back to reference Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ, Rubinsztein DC: Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol. 2005, 170: 1101-1111. 10.1083/jcb.200504035.PubMedCentralPubMed Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ, Rubinsztein DC: Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol. 2005, 170: 1101-1111. 10.1083/jcb.200504035.PubMedCentralPubMed
32.
go back to reference Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC: Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and {alpha}-Synuclein. J Biol Chem. 2007, 282: 5641-5652. 10.1074/jbc.M609532200.PubMed Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC: Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and {alpha}-Synuclein. J Biol Chem. 2007, 282: 5641-5652. 10.1074/jbc.M609532200.PubMed
33.
go back to reference Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A, Maglathlin RL, Webster JA, Lewis TA, O'Kane CJ, Schreiber SL, Rubinsztein DC: Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol. 2007, 3: 331-338. 10.1038/nchembio883.PubMedCentralPubMed Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A, Maglathlin RL, Webster JA, Lewis TA, O'Kane CJ, Schreiber SL, Rubinsztein DC: Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol. 2007, 3: 331-338. 10.1038/nchembio883.PubMedCentralPubMed
34.
go back to reference Berger Z, Ravikumar B, Menzies FM, Oroz LG, Underwood BR, Pangalos MN, Schmitt I, Wullner U, Evert BO, O'Kane CJ, Rubinsztein DC: Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet. 2006, 15: 433-442. 10.1093/hmg/ddi458.PubMed Berger Z, Ravikumar B, Menzies FM, Oroz LG, Underwood BR, Pangalos MN, Schmitt I, Wullner U, Evert BO, O'Kane CJ, Rubinsztein DC: Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet. 2006, 15: 433-442. 10.1093/hmg/ddi458.PubMed
35.
go back to reference Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O'Kane CJ, Rubinsztein DC: Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004, 36: 585-595. 10.1038/ng1362.PubMed Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O'Kane CJ, Rubinsztein DC: Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004, 36: 585-595. 10.1038/ng1362.PubMed
36.
go back to reference Massey AC, Kaushik S, Sovak G, Kiffin R, Cuervo AM: Consequences of the selective blockage of chaperone-mediated autophagy. Proc Natl Acad Sci USA. 2006, 103: 5805-5810. 10.1073/pnas.0507436103.PubMedCentralPubMed Massey AC, Kaushik S, Sovak G, Kiffin R, Cuervo AM: Consequences of the selective blockage of chaperone-mediated autophagy. Proc Natl Acad Sci USA. 2006, 103: 5805-5810. 10.1073/pnas.0507436103.PubMedCentralPubMed
37.
go back to reference McCray BA, Taylor JP: The role of autophagy in age-related neurodegeneration. Neurosignals. 2008, 16 (1): 75-84. 10.1159/000109761.PubMed McCray BA, Taylor JP: The role of autophagy in age-related neurodegeneration. Neurosignals. 2008, 16 (1): 75-84. 10.1159/000109761.PubMed
38.
go back to reference Kiffin R, Christian C, Knecht E, Cuervo AM: Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell. 2004, 15: 4829-4840. 10.1091/mbc.E04-06-0477.PubMedCentralPubMed Kiffin R, Christian C, Knecht E, Cuervo AM: Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell. 2004, 15: 4829-4840. 10.1091/mbc.E04-06-0477.PubMedCentralPubMed
39.
go back to reference Grune T, Reinheckel T, Joshi M, Davies KJ: Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome. J Biol Chem. 1995, 270: 2344-2351. 10.1074/jbc.270.5.2344.PubMed Grune T, Reinheckel T, Joshi M, Davies KJ: Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome. J Biol Chem. 1995, 270: 2344-2351. 10.1074/jbc.270.5.2344.PubMed
40.
go back to reference Grune T, Blasig IE, Sitte N, Roloff B, Haseloff R, Davies KJ: Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. J Biol Chem. 1998, 273: 10857-10862. 10.1074/jbc.273.18.10857.PubMed Grune T, Blasig IE, Sitte N, Roloff B, Haseloff R, Davies KJ: Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome. J Biol Chem. 1998, 273: 10857-10862. 10.1074/jbc.273.18.10857.PubMed
41.
go back to reference Davies KJ: Degradation of oxidized proteins by the 20S proteasome. Biochimie. 2001, 83: 301-310. 10.1016/S0300-9084(01)01250-0.PubMed Davies KJ: Degradation of oxidized proteins by the 20S proteasome. Biochimie. 2001, 83: 301-310. 10.1016/S0300-9084(01)01250-0.PubMed
42.
go back to reference Grune T, Reinheckel T, Davies KJ: Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J Biol Chem. 1996, 271: 15504-15509. 10.1074/jbc.271.26.15504.PubMed Grune T, Reinheckel T, Davies KJ: Degradation of oxidized proteins in K562 human hematopoietic cells by proteasome. J Biol Chem. 1996, 271: 15504-15509. 10.1074/jbc.271.26.15504.PubMed
43.
go back to reference Sitte N, Merker K, Grune T: Proteasome-dependent degradation of oxidized proteins in MRC-5 fibroblasts. FEBS lett. 1998, 440: 399-402. 10.1016/S0014-5793(98)01495-1.PubMed Sitte N, Merker K, Grune T: Proteasome-dependent degradation of oxidized proteins in MRC-5 fibroblasts. FEBS lett. 1998, 440: 399-402. 10.1016/S0014-5793(98)01495-1.PubMed
44.
go back to reference Ullrich O, Reinheckel T, Sitte N, Grune T: Degradation of hypochlorite-damaged glucose-6-phosphate dehydrogenase by the 20S proteasome. Free Radic Biol Med. 1999, 27: 487-492. 10.1016/S0891-5849(99)00060-X.PubMed Ullrich O, Reinheckel T, Sitte N, Grune T: Degradation of hypochlorite-damaged glucose-6-phosphate dehydrogenase by the 20S proteasome. Free Radic Biol Med. 1999, 27: 487-492. 10.1016/S0891-5849(99)00060-X.PubMed
45.
go back to reference Friguet B, Szweda LI: Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS lett. 1997, 405: 21-25. 10.1016/S0014-5793(97)00148-8.PubMed Friguet B, Szweda LI: Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS lett. 1997, 405: 21-25. 10.1016/S0014-5793(97)00148-8.PubMed
46.
go back to reference Friguet B, Stadtman ER, Szweda LI: Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. J Biol Chem. 1994, 269 (24): 21639-21643.PubMed Friguet B, Stadtman ER, Szweda LI: Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. J Biol Chem. 1994, 269 (24): 21639-21643.PubMed
47.
go back to reference Sitte N, Merker K, Von Zglinicki T, Grune T, Davies KJ: Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I–effects of proliferative senescence. Faseb J. 2000, 14: 2495-2502. 10.1096/fj.00-0209com.PubMed Sitte N, Merker K, Von Zglinicki T, Grune T, Davies KJ: Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I–effects of proliferative senescence. Faseb J. 2000, 14: 2495-2502. 10.1096/fj.00-0209com.PubMed
48.
go back to reference Sitte N, Huber M, Grune T, Ladhoff A, Doecke W-D, Von Zglinicki T, Davies KJA: Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J. 2000, 14: 1490-1498. 10.1096/fj.14.11.1490.PubMed Sitte N, Huber M, Grune T, Ladhoff A, Doecke W-D, Von Zglinicki T, Davies KJA: Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J. 2000, 14: 1490-1498. 10.1096/fj.14.11.1490.PubMed
49.
go back to reference Keller JN, Huang FF, Dimayuga ER, Maragos WF: Dopamine induces proteasome inhibition in neural PC12 cell line. Free Radic Biol Med. 2000, 29: 1037-1042. 10.1016/S0891-5849(00)00412-3.PubMed Keller JN, Huang FF, Dimayuga ER, Maragos WF: Dopamine induces proteasome inhibition in neural PC12 cell line. Free Radic Biol Med. 2000, 29: 1037-1042. 10.1016/S0891-5849(00)00412-3.PubMed
50.
go back to reference Keller JN, Huang FF, Markesbery WR: Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience. 2000, 98: 149-156. 10.1016/S0306-4522(00)00067-1.PubMed Keller JN, Huang FF, Markesbery WR: Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience. 2000, 98: 149-156. 10.1016/S0306-4522(00)00067-1.PubMed
51.
go back to reference Keller JN, Huang FF, Zhu H, Yu J, Ho YS, Kindy TS: Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury. J Cereb Blood Flow Metab. 2000, 20: 1467-1473. 10.1097/00004647-200010000-00008.PubMed Keller JN, Huang FF, Zhu H, Yu J, Ho YS, Kindy TS: Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury. J Cereb Blood Flow Metab. 2000, 20: 1467-1473. 10.1097/00004647-200010000-00008.PubMed
52.
go back to reference Shamoto-Nagai M, Maruyama W, Kato Y, Isobe K, Tanaka M, Naoi M, Osawa T: An inhibitor of mitochondrial complex I, rotenone inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells. J Neurosci Res. 2003, 74: 589-597. 10.1002/jnr.10777.PubMed Shamoto-Nagai M, Maruyama W, Kato Y, Isobe K, Tanaka M, Naoi M, Osawa T: An inhibitor of mitochondrial complex I, rotenone inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells. J Neurosci Res. 2003, 74: 589-597. 10.1002/jnr.10777.PubMed
53.
go back to reference Okada K, Wangpoengtrakul C, Osawa T, Toyokuni S, Tanaka K, Uchida K: 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J Biol Chem. 1999, 274: 23787-23793. 10.1074/jbc.274.34.23787.PubMed Okada K, Wangpoengtrakul C, Osawa T, Toyokuni S, Tanaka K, Uchida K: 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J Biol Chem. 1999, 274: 23787-23793. 10.1074/jbc.274.34.23787.PubMed
54.
go back to reference Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, Friguet B, Szweda LI: Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem. 2001, 276: 30057-30063. 10.1074/jbc.M100142200.PubMed Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, Friguet B, Szweda LI: Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem. 2001, 276: 30057-30063. 10.1074/jbc.M100142200.PubMed
55.
go back to reference Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, Hodara R, Fredenburg R, Wu DC, Follenzi A, Dauer W, Przedborski S, Ischiropoulos H, Lansbury PT, Sulzer D, Cuervo AM: Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest. 2008, 118 (2): 777-788.PubMedCentralPubMed Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, Hodara R, Fredenburg R, Wu DC, Follenzi A, Dauer W, Przedborski S, Ischiropoulos H, Lansbury PT, Sulzer D, Cuervo AM: Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest. 2008, 118 (2): 777-788.PubMedCentralPubMed
56.
go back to reference Wan FY, Wang YN, Zhang GJ: The influence of oxidation of membrane thiol groups on lysosomal proton permeability. Biochem J. 2001, 360: 355-362. 10.1042/0264-6021:3600355.PubMedCentralPubMed Wan FY, Wang YN, Zhang GJ: The influence of oxidation of membrane thiol groups on lysosomal proton permeability. Biochem J. 2001, 360: 355-362. 10.1042/0264-6021:3600355.PubMedCentralPubMed
57.
go back to reference Brunk UT, Dalen H, Roberg K, Hellquist HB: Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic Biol Med. 1997, 23: 616-626. 10.1016/S0891-5849(97)00007-5.PubMed Brunk UT, Dalen H, Roberg K, Hellquist HB: Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic Biol Med. 1997, 23: 616-626. 10.1016/S0891-5849(97)00007-5.PubMed
58.
go back to reference Brunk UT, Terman A: Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med. 2002, 33: 611-619. 10.1016/S0891-5849(02)00959-0.PubMed Brunk UT, Terman A: Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med. 2002, 33: 611-619. 10.1016/S0891-5849(02)00959-0.PubMed
59.
go back to reference Ditaranto K, Tekirian TL, Yang AJ: Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol Dis. 2001, 8: 19-31. 10.1006/nbdi.2000.0364.PubMed Ditaranto K, Tekirian TL, Yang AJ: Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol Dis. 2001, 8: 19-31. 10.1006/nbdi.2000.0364.PubMed
60.
go back to reference Langston JW, Ballard P, Tetrud JW, Irwin I: Chronic Parkinsonism in Humans due to a Product of Meperidine-Analog Synthesis. Science. 1983, 219: 979-980. 10.1126/science.6823561.PubMed Langston JW, Ballard P, Tetrud JW, Irwin I: Chronic Parkinsonism in Humans due to a Product of Meperidine-Analog Synthesis. Science. 1983, 219: 979-980. 10.1126/science.6823561.PubMed
61.
go back to reference Olanow CW, Tatton WG: Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci. 1999, 22: 123-144. 10.1146/annurev.neuro.22.1.123.PubMed Olanow CW, Tatton WG: Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci. 1999, 22: 123-144. 10.1146/annurev.neuro.22.1.123.PubMed
62.
go back to reference Choi WS, Kruse SE, Palmiter RD, Xia Z: Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc Natl Acad Sci USA. 2008, 105: 15136-15141. 10.1073/pnas.0807581105.PubMedCentralPubMed Choi WS, Kruse SE, Palmiter RD, Xia Z: Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc Natl Acad Sci USA. 2008, 105: 15136-15141. 10.1073/pnas.0807581105.PubMedCentralPubMed
63.
go back to reference Forno LS, Langston JW, DeLanney LE, Irwin I: An electron microscopic study of MPTP-induced inclusion bodies in an old monkey. Brain Res. 1988, 448: 150-157. 10.1016/0006-8993(88)91111-0.PubMed Forno LS, Langston JW, DeLanney LE, Irwin I: An electron microscopic study of MPTP-induced inclusion bodies in an old monkey. Brain Res. 1988, 448: 150-157. 10.1016/0006-8993(88)91111-0.PubMed
64.
go back to reference Kowall NW, Hantraye P, Brouillet E, Beal MF, McKee AC, Ferrante RJ: MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Neuroreport. 2000, 11: 211-213. 10.1097/00001756-200001170-00041.PubMed Kowall NW, Hantraye P, Brouillet E, Beal MF, McKee AC, Ferrante RJ: MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Neuroreport. 2000, 11: 211-213. 10.1097/00001756-200001170-00041.PubMed
65.
go back to reference Forno L, Langston J, DeLanney L, Irwin I, Ricaurte G: Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol. 1986, 20: 449-455. 10.1002/ana.410200403.PubMed Forno L, Langston J, DeLanney L, Irwin I, Ricaurte G: Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol. 1986, 20: 449-455. 10.1002/ana.410200403.PubMed
66.
go back to reference Moratalla R, Quinn B, DeLanney LE, Irwin I, Langston JW, Graybiel AM: Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA. 1992, 89: 3859-3863. 10.1073/pnas.89.9.3859.PubMedCentralPubMed Moratalla R, Quinn B, DeLanney LE, Irwin I, Langston JW, Graybiel AM: Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA. 1992, 89: 3859-3863. 10.1073/pnas.89.9.3859.PubMedCentralPubMed
67.
go back to reference Przedborski S, Chen Q, Vila M, Giasson BI, Djaldatti R, Vukosavic S, Souza JM, Jackson-Lewis V, Lee VM, Ischiropoulos H: Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J Neurochem. 2001, 76: 637-640. 10.1046/j.1471-4159.2001.00174.x.PubMed Przedborski S, Chen Q, Vila M, Giasson BI, Djaldatti R, Vukosavic S, Souza JM, Jackson-Lewis V, Lee VM, Ischiropoulos H: Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J Neurochem. 2001, 76: 637-640. 10.1046/j.1471-4159.2001.00174.x.PubMed
68.
go back to reference Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S: Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med. 1999, 5: 1403-10.1038/70978.PubMed Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, Dawson VL, Dawson TM, Przedborski S: Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med. 1999, 5: 1403-10.1038/70978.PubMed
69.
go back to reference Matthews RT, Beal MF, Fallon J, Fedorchak K, Huang PL, Fishman MC, Hyman BT: MPP+Induced Substantia Nigra Degeneration Is Attenuated in nNOS Knockout Mice. Neurobiol Dis. 1997, 4: 114-121. 10.1006/nbdi.1997.0141.PubMed Matthews RT, Beal MF, Fallon J, Fedorchak K, Huang PL, Fishman MC, Hyman BT: MPP+Induced Substantia Nigra Degeneration Is Attenuated in nNOS Knockout Mice. Neurobiol Dis. 1997, 4: 114-121. 10.1006/nbdi.1997.0141.PubMed
70.
go back to reference Schulz BJ, Henshaw DR, Matthews RT, Beal MF: Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity. Exp Neurol. 1995, 132: 279-283. 10.1016/0014-4886(95)90033-0.PubMed Schulz BJ, Henshaw DR, Matthews RT, Beal MF: Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity. Exp Neurol. 1995, 132: 279-283. 10.1016/0014-4886(95)90033-0.PubMed
71.
go back to reference Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM: Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA. 1996, 93: 4565-4571. 10.1073/pnas.93.10.4565.PubMedCentralPubMed Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM: Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA. 1996, 93: 4565-4571. 10.1073/pnas.93.10.4565.PubMedCentralPubMed
72.
go back to reference Brooks AI, Chadwick CA, Gelbard HA, Cory-Slechta DA, Federoff HJ: Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res. 1999, 823: 1-10. 10.1016/S0006-8993(98)01192-5.PubMed Brooks AI, Chadwick CA, Gelbard HA, Cory-Slechta DA, Federoff HJ: Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res. 1999, 823: 1-10. 10.1016/S0006-8993(98)01192-5.PubMed
73.
go back to reference McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA, Di Monte DA: Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat. Neurobiol Dis. 2002, 10: 119-127. 10.1006/nbdi.2002.0507.PubMed McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, Cory-Slechta DA, Di Monte DA: Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat. Neurobiol Dis. 2002, 10: 119-127. 10.1006/nbdi.2002.0507.PubMed
74.
go back to reference Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA: The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem. 2002, 277: 1641-1644. 10.1074/jbc.C100560200.PubMed Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA: The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem. 2002, 277: 1641-1644. 10.1074/jbc.C100560200.PubMed
75.
go back to reference Vila M, Vukosavic S, Jackson-Lewis V, Neystat M, Jakowec M, Przedborski S: Alpha-Synuclein Up-Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP. J Neurochem. 2000, 74: 721-729. 10.1046/j.1471-4159.2000.740721.x.PubMed Vila M, Vukosavic S, Jackson-Lewis V, Neystat M, Jakowec M, Przedborski S: Alpha-Synuclein Up-Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP. J Neurochem. 2000, 74: 721-729. 10.1046/j.1471-4159.2000.740721.x.PubMed
76.
go back to reference Elroy-Stein O, Bernstein Y, Groner Y: Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation. EMBO J. 1986, 5 (3): 615-622.PubMedCentralPubMed Elroy-Stein O, Bernstein Y, Groner Y: Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation. EMBO J. 1986, 5 (3): 615-622.PubMedCentralPubMed
77.
go back to reference St. Clair DK, Oberley TD, Ho Y-S: Overproduction of human Mn-superoxide dismutase modulates paraquat-mediated toxicity in mammalian cells. FEBS lett. 1991, 293: 199-203. 10.1016/0014-5793(91)81186-C.PubMed St. Clair DK, Oberley TD, Ho Y-S: Overproduction of human Mn-superoxide dismutase modulates paraquat-mediated toxicity in mammalian cells. FEBS lett. 1991, 293: 199-203. 10.1016/0014-5793(91)81186-C.PubMed
78.
go back to reference Thiruchelvam M, Prokopenko O, Cory-Slechta DA, Richfield EK, Buckley B, Mirochnitchenko O: Overexpression of Superoxide Dismutase or Glutathione Peroxidase Protects against the Paraquat + Maneb-induced Parkinson Disease Phenotype. J Biol Chem. 2005, 280: 22530-22539. 10.1074/jbc.M500417200.PubMed Thiruchelvam M, Prokopenko O, Cory-Slechta DA, Richfield EK, Buckley B, Mirochnitchenko O: Overexpression of Superoxide Dismutase or Glutathione Peroxidase Protects against the Paraquat + Maneb-induced Parkinson Disease Phenotype. J Biol Chem. 2005, 280: 22530-22539. 10.1074/jbc.M500417200.PubMed
79.
go back to reference Dong A, Shen J, Krause M, Akiyama H, Hackett SF, Lai H, Campochiaro PA: Superoxide dismutase 1 protects retinal cells from oxidative damage. J Cell Physiol. 2006, 208: 516-526. 10.1002/jcp.20683.PubMed Dong A, Shen J, Krause M, Akiyama H, Hackett SF, Lai H, Campochiaro PA: Superoxide dismutase 1 protects retinal cells from oxidative damage. J Cell Physiol. 2006, 208: 516-526. 10.1002/jcp.20683.PubMed
80.
go back to reference Patel M, Day BJ, Crapo JD, Fridovich I, McNamara JO: Requirement for Superoxide in Excitotoxic Cell Death. Neuron. 1996, 16: 345-355. 10.1016/S0896-6273(00)80052-5.PubMed Patel M, Day BJ, Crapo JD, Fridovich I, McNamara JO: Requirement for Superoxide in Excitotoxic Cell Death. Neuron. 1996, 16: 345-355. 10.1016/S0896-6273(00)80052-5.PubMed
81.
go back to reference Day BJ, Shawen S, Liochev SI, Crapo JD: A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced endothelial cell injury in vitro. J Pharmacol Exp Ther. 1995, 275 (3): 1227-1232.PubMed Day BJ, Shawen S, Liochev SI, Crapo JD: A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced endothelial cell injury in vitro. J Pharmacol Exp Ther. 1995, 275 (3): 1227-1232.PubMed
82.
go back to reference Peng J, Stevenson FF, Doctrow SR, Andersen JK: Superoxide Dismutase/Catalase Mimetics Are Neuroprotective against Selective Paraquat-mediated Dopaminergic Neuron Death in the Substantial Nigra: Implications For Parkinson Disease. J Biol Chem. 2005, 280: 29194-29198. 10.1074/jbc.M500984200.PubMed Peng J, Stevenson FF, Doctrow SR, Andersen JK: Superoxide Dismutase/Catalase Mimetics Are Neuroprotective against Selective Paraquat-mediated Dopaminergic Neuron Death in the Substantial Nigra: Implications For Parkinson Disease. J Biol Chem. 2005, 280: 29194-29198. 10.1074/jbc.M500984200.PubMed
83.
go back to reference Tauskela JS, Brunette E, O'Reilly N, Mealing G, Comas T, Gendron TF, Monette R, Morley P: An alternative Ca2+-dependent mechanism of neuroprotection by the metalloporphyrin class of superoxide dismutase mimetics. FASEB J. 2005, 19 (12): 1734-1736.PubMed Tauskela JS, Brunette E, O'Reilly N, Mealing G, Comas T, Gendron TF, Monette R, Morley P: An alternative Ca2+-dependent mechanism of neuroprotection by the metalloporphyrin class of superoxide dismutase mimetics. FASEB J. 2005, 19 (12): 1734-1736.PubMed
84.
go back to reference Rebouças J, Spasojević I, Batinić-Haberle I: Pure manganese(III) 5,10,15,20-tetrakis(4-benzoic acid)porphyrin (MnTBAP) is not a superoxide dismutase mimic in aqueous systems: a case of structure-activity relationship as a watchdog mechanism in experimental therapeutics and biology. J Biol Inorg Chem. 2008, 13: 289-302. 10.1007/s00775-007-0324-9.PubMed Rebouças J, Spasojević I, Batinić-Haberle I: Pure manganese(III) 5,10,15,20-tetrakis(4-benzoic acid)porphyrin (MnTBAP) is not a superoxide dismutase mimic in aqueous systems: a case of structure-activity relationship as a watchdog mechanism in experimental therapeutics and biology. J Biol Inorg Chem. 2008, 13: 289-302. 10.1007/s00775-007-0324-9.PubMed
85.
go back to reference Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT: Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci. 2000, 3: 1301-1306. 10.1038/81834.PubMed Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT: Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci. 2000, 3: 1301-1306. 10.1038/81834.PubMed
86.
go back to reference Dauer W, Przedborski S: Parkinson's disease: mechanisms and models. Neuron. 2003, 39: 889-909. 10.1016/S0896-6273(03)00568-3.PubMed Dauer W, Przedborski S: Parkinson's disease: mechanisms and models. Neuron. 2003, 39: 889-909. 10.1016/S0896-6273(03)00568-3.PubMed
87.
go back to reference Dunnett SB, Bjorklund A: Prospects for new restorative and neuroprotective treatments in Parkinson's disease. (cover story). Nature. 1999, 399: A32-10.1038/19899.PubMed Dunnett SB, Bjorklund A: Prospects for new restorative and neuroprotective treatments in Parkinson's disease. (cover story). Nature. 1999, 399: A32-10.1038/19899.PubMed
88.
go back to reference Jenner P, Olanow CW: Understanding cell death in Parkinson's disease. Ann Neurol. 1998, 44 (3 Suppl 1): S72-S84.PubMed Jenner P, Olanow CW: Understanding cell death in Parkinson's disease. Ann Neurol. 1998, 44 (3 Suppl 1): S72-S84.PubMed
89.
go back to reference Cohen G, Heikkila RE, MacNamee D: The Generation of Hydrogen Peroxide Superoxide Radical and Hydroxyl Radical by 6-Hydroxydopamine Dialuric Acid and Related Cytotoxic Agents. J Biol Chem. 1974, 249 (8): 2447-2452.PubMed Cohen G, Heikkila RE, MacNamee D: The Generation of Hydrogen Peroxide Superoxide Radical and Hydroxyl Radical by 6-Hydroxydopamine Dialuric Acid and Related Cytotoxic Agents. J Biol Chem. 1974, 249 (8): 2447-2452.PubMed
90.
go back to reference Jeon BS, Jackson-Lewis V, Burke RE: 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration. 1995, 4: 131-137. 10.1006/neur.1995.0016.PubMed Jeon BS, Jackson-Lewis V, Burke RE: 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration. 1995, 4: 131-137. 10.1006/neur.1995.0016.PubMed
91.
go back to reference Sauer H, Oertel WH: Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat. Neuroscience. 1994, 59: 401-415. 10.1016/0306-4522(94)90605-X.PubMed Sauer H, Oertel WH: Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat. Neuroscience. 1994, 59: 401-415. 10.1016/0306-4522(94)90605-X.PubMed
92.
go back to reference Przedbroski S, Leviver M, Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D, Togasaki DM: Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by instrastriatal injection of 6-hydroxydopamine. Neuroscience. 1995, 67: 631-647. 10.1016/0306-4522(95)00066-R. Przedbroski S, Leviver M, Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D, Togasaki DM: Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by instrastriatal injection of 6-hydroxydopamine. Neuroscience. 1995, 67: 631-647. 10.1016/0306-4522(95)00066-R.
93.
go back to reference Thomas B, Beal MF: Parkinson's disease. Hum Mol Genet. 2007, 16 (Spec No 2): R183-194. 10.1093/hmg/ddm159.PubMed Thomas B, Beal MF: Parkinson's disease. Hum Mol Genet. 2007, 16 (Spec No 2): R183-194. 10.1093/hmg/ddm159.PubMed
94.
go back to reference Lesage S, Brice A: Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet. 2009, 18: R48-59. 10.1093/hmg/ddp012.PubMed Lesage S, Brice A: Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet. 2009, 18: R48-59. 10.1093/hmg/ddp012.PubMed
95.
go back to reference Gasser T: Mendelian forms of Parkinson's disease. Biochim Biophys Acta. 2009 Gasser T: Mendelian forms of Parkinson's disease. Biochim Biophys Acta. 2009
96.
go back to reference Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, Cid LP, Goebel I, Mubaidin AF, Wriekat A-L, Roeper J, Al-Din A, Hillmer AM, Karsak M, Liss B, Woods CG, Behrens MI, Kubisch C: Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet. 2006, 38: 1184-1191. 10.1038/ng1884.PubMed Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, Cid LP, Goebel I, Mubaidin AF, Wriekat A-L, Roeper J, Al-Din A, Hillmer AM, Karsak M, Liss B, Woods CG, Behrens MI, Kubisch C: Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet. 2006, 38: 1184-1191. 10.1038/ng1884.PubMed
97.
go back to reference Gitler A, Chesi A, Geddie M, Strathearn K, Hamamichi S, Hill K, Caldwell K, Caldwell G, Cooper A, Rochet J, Lindquist S: Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet. 2009, 41: 308-315. 10.1038/ng.300.PubMedCentralPubMed Gitler A, Chesi A, Geddie M, Strathearn K, Hamamichi S, Hill K, Caldwell K, Caldwell G, Cooper A, Rochet J, Lindquist S: Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet. 2009, 41: 308-315. 10.1038/ng.300.PubMedCentralPubMed
98.
go back to reference Andres-Mateos E, Perier C, Zhang L, Blanchard-Fillion B, Greco TM, Thomas B, Ko HS, Sasaki M, Ischiropoulos H, Przedborski S, Dawson TM, Dawson VL: DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc Natl Acad Sci USA. 2007, 104: 14807-14812. 10.1073/pnas.0703219104.PubMedCentralPubMed Andres-Mateos E, Perier C, Zhang L, Blanchard-Fillion B, Greco TM, Thomas B, Ko HS, Sasaki M, Ischiropoulos H, Przedborski S, Dawson TM, Dawson VL: DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc Natl Acad Sci USA. 2007, 104: 14807-14812. 10.1073/pnas.0703219104.PubMedCentralPubMed
99.
go back to reference Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, Ariga H: DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 2004, 5: 213-218. 10.1038/sj.embor.7400074.PubMedCentralPubMed Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, Ariga H: DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 2004, 5: 213-218. 10.1038/sj.embor.7400074.PubMedCentralPubMed
100.
go back to reference Mitsumoto A, Nakagawa Y, Takeuchi A, Okawa K, Iwamatsu A, Takanezawa Y: Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat. Free Radic Res. 2001, 35: 301-310. 10.1080/10715760100300831.PubMed Mitsumoto A, Nakagawa Y, Takeuchi A, Okawa K, Iwamatsu A, Takanezawa Y: Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat. Free Radic Res. 2001, 35: 301-310. 10.1080/10715760100300831.PubMed
101.
go back to reference Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, Bandyopadhyay S, Baptista MJ, Ringe D, Petsko GA, Cookson MR: The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA. 2004, 101: 9103-9108. 10.1073/pnas.0402959101.PubMedCentralPubMed Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, Bandyopadhyay S, Baptista MJ, Ringe D, Petsko GA, Cookson MR: The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA. 2004, 101: 9103-9108. 10.1073/pnas.0402959101.PubMedCentralPubMed
102.
go back to reference Meulener MC, Xu K, Thomson L, Ischiropoulos H, Bonini NM: Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging. Proc Natl Acad Sci USA. 2006, 103: 12517-12522. 10.1073/pnas.0601891103.PubMedCentralPubMed Meulener MC, Xu K, Thomson L, Ischiropoulos H, Bonini NM: Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging. Proc Natl Acad Sci USA. 2006, 103: 12517-12522. 10.1073/pnas.0601891103.PubMedCentralPubMed
103.
go back to reference Martinat C, Shendelman S, Jonason A, Leete T, Beal MF, Yang L, Floss T, Abeliovich A: Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism. PLoS biology. 2004, 2: e327-10.1371/journal.pbio.0020327.PubMedCentralPubMed Martinat C, Shendelman S, Jonason A, Leete T, Beal MF, Yang L, Floss T, Abeliovich A: Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism. PLoS biology. 2004, 2: e327-10.1371/journal.pbio.0020327.PubMedCentralPubMed
104.
go back to reference Yang Y, Gehrke S, Haque ME, Imai Y, Kosek J, Yang L, Beal MF, Nishimura I, Wakamatsu K, Ito S, Takahashi R, Lu B: Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc Natl Acad Sci USA. 2005, 102: 13670-13675. 10.1073/pnas.0504610102.PubMedCentralPubMed Yang Y, Gehrke S, Haque ME, Imai Y, Kosek J, Yang L, Beal MF, Nishimura I, Wakamatsu K, Ito S, Takahashi R, Lu B: Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc Natl Acad Sci USA. 2005, 102: 13670-13675. 10.1073/pnas.0504610102.PubMedCentralPubMed
105.
go back to reference Meulener M, Whitworth AJ, Armstrong-Gold CE, Rizzu P, Heutink P, Wes PD, Pallanck LJ, Bonini NM: Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr Biol. 2005, 15: 1572-1577. 10.1016/j.cub.2005.07.064.PubMed Meulener M, Whitworth AJ, Armstrong-Gold CE, Rizzu P, Heutink P, Wes PD, Pallanck LJ, Bonini NM: Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Curr Biol. 2005, 15: 1572-1577. 10.1016/j.cub.2005.07.064.PubMed
106.
go back to reference Park J, Kim SY, Cha GH, Lee SB, Kim S, Chung J: Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene. 2005, 361: 133-139. 10.1016/j.gene.2005.06.040.PubMed Park J, Kim SY, Cha GH, Lee SB, Kim S, Chung J: Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene. 2005, 361: 133-139. 10.1016/j.gene.2005.06.040.PubMed
107.
go back to reference Menzies FM, Yenisetti SC, Min KT: Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress. Curr Biol. 2005, 15: 1578-1582. 10.1016/j.cub.2005.07.036.PubMed Menzies FM, Yenisetti SC, Min KT: Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress. Curr Biol. 2005, 15: 1578-1582. 10.1016/j.cub.2005.07.036.PubMed
108.
go back to reference Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, Pownall S, Wakeham A, You-Ten AJ, Kalia SK, Horne P, Westaway D, Lozano AM, Anisman H, Park DS, Mak TW: Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci USA. 2005, 102: 5215-5220. 10.1073/pnas.0501282102.PubMedCentralPubMed Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, Pownall S, Wakeham A, You-Ten AJ, Kalia SK, Horne P, Westaway D, Lozano AM, Anisman H, Park DS, Mak TW: Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci USA. 2005, 102: 5215-5220. 10.1073/pnas.0501282102.PubMedCentralPubMed
109.
go back to reference Zhou W, Freed CR: DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J Biol Chem. 2005, 280: 43150-43158. 10.1074/jbc.M507124200.PubMed Zhou W, Freed CR: DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity. J Biol Chem. 2005, 280: 43150-43158. 10.1074/jbc.M507124200.PubMed
110.
go back to reference Inden M, Taira T, Kitamura Y, Yanagida T, Tsuchiya D, Takata K, Yanagisawa D, Nishimura K, Taniguchi T, Kiso Y, Yoshimoto K, Agatsuma T, Koide-Yoshida S, Iguchi-Ariga SM, Shimohama S, Ariga H: PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Neurobiol Dis. 2006, 24: 144-158. 10.1016/j.nbd.2006.06.004.PubMed Inden M, Taira T, Kitamura Y, Yanagida T, Tsuchiya D, Takata K, Yanagisawa D, Nishimura K, Taniguchi T, Kiso Y, Yoshimoto K, Agatsuma T, Koide-Yoshida S, Iguchi-Ariga SM, Shimohama S, Ariga H: PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Neurobiol Dis. 2006, 24: 144-158. 10.1016/j.nbd.2006.06.004.PubMed
111.
go back to reference Paterna JC, Leng A, Weber E, Feldon J, Bueler H: DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol Ther. 2007, 15: 698-704. 10.1038/sj.mt.6300154.PubMed Paterna JC, Leng A, Weber E, Feldon J, Bueler H: DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol Ther. 2007, 15: 698-704. 10.1038/sj.mt.6300154.PubMed
112.
go back to reference Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW: Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science. 2004, 304: 1158-1160. 10.1126/science.1096284.PubMed Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW: Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science. 2004, 304: 1158-1160. 10.1126/science.1096284.PubMed
113.
go back to reference Sim CH, Lio DS, Mok SS, Masters CL, Hill AF, Culvenor JG, Cheng HC: C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum Mol Genet. 2006, 15: 3251-3262. 10.1093/hmg/ddl398.PubMed Sim CH, Lio DS, Mok SS, Masters CL, Hill AF, Culvenor JG, Cheng HC: C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum Mol Genet. 2006, 15: 3251-3262. 10.1093/hmg/ddl398.PubMed
114.
go back to reference Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B, Valente EM, Casari G: Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet. 2005, 14: 3477-3492. 10.1093/hmg/ddi377.PubMed Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B, Valente EM, Casari G: Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet. 2005, 14: 3477-3492. 10.1093/hmg/ddi377.PubMed
115.
go back to reference Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, Scheid M, Chen F, Gu Y, Hasegawa H, Salehi-Rad S, Wang L, Rogaeva E, Fraser P, Robinson B, St George-Hyslop P, Tandon A: Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem. 2005, 280: 34025-34032. 10.1074/jbc.M505143200.PubMed Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, Scheid M, Chen F, Gu Y, Hasegawa H, Salehi-Rad S, Wang L, Rogaeva E, Fraser P, Robinson B, St George-Hyslop P, Tandon A: Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem. 2005, 280: 34025-34032. 10.1074/jbc.M505143200.PubMed
116.
go back to reference Deng H, Dodson MW, Huang H, Guo M: The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci USA. 2008, 105: 14503-14508. 10.1073/pnas.0803998105.PubMedCentralPubMed Deng H, Dodson MW, Huang H, Guo M: The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci USA. 2008, 105: 14503-14508. 10.1073/pnas.0803998105.PubMedCentralPubMed
117.
go back to reference Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, Pallanck LJ: The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci USA. 2008, 105: 1638-1643. 10.1073/pnas.0709336105.PubMedCentralPubMed Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, Pallanck LJ: The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci USA. 2008, 105: 1638-1643. 10.1073/pnas.0709336105.PubMedCentralPubMed
118.
go back to reference Yang Y, Ouyang Y, Yang L, Beal MF, McQuibban A, Vogel H, Lu B: Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci USA. 2008, 105: 7070-7075. 10.1073/pnas.0711845105.PubMedCentralPubMed Yang Y, Ouyang Y, Yang L, Beal MF, McQuibban A, Vogel H, Lu B: Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci USA. 2008, 105: 7070-7075. 10.1073/pnas.0711845105.PubMedCentralPubMed
119.
go back to reference Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D, Harvey K, Deas E, Harvey RJ, McDonald N, Wood NW, Martins LM, Downward J: The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol. 2007, 9: 1243-1252. 10.1038/ncb1644.PubMed Plun-Favreau H, Klupsch K, Moisoi N, Gandhi S, Kjaer S, Frith D, Harvey K, Deas E, Harvey RJ, McDonald N, Wood NW, Martins LM, Downward J: The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol. 2007, 9: 1243-1252. 10.1038/ncb1644.PubMed
120.
go back to reference Exner N, Treske B, Paquet D, Holmstrom K, Schiesling C, Gispert S, Carballo-Carbajal I, Berg D, Hoepken HH, Gasser T, Kruger R, Winklhofer KF, Vogel F, Reichert AS, Auburger G, Kahle PJ, Schmid B, Haass C: Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci. 2007, 27: 12413-12418. 10.1523/JNEUROSCI.0719-07.2007.PubMed Exner N, Treske B, Paquet D, Holmstrom K, Schiesling C, Gispert S, Carballo-Carbajal I, Berg D, Hoepken HH, Gasser T, Kruger R, Winklhofer KF, Vogel F, Reichert AS, Auburger G, Kahle PJ, Schmid B, Haass C: Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci. 2007, 27: 12413-12418. 10.1523/JNEUROSCI.0719-07.2007.PubMed
121.
go back to reference Hoepken HH, Gispert S, Morales B, Wingerter O, Del Turco D, Mulsch A, Nussbaum RL, Muller K, Drose S, Brandt U, Deller T, Wirth B, Kudin AP, Kunz WS, Auburger G: Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiol Dis. 2007, 25: 401-411. 10.1016/j.nbd.2006.10.007.PubMed Hoepken HH, Gispert S, Morales B, Wingerter O, Del Turco D, Mulsch A, Nussbaum RL, Muller K, Drose S, Brandt U, Deller T, Wirth B, Kudin AP, Kunz WS, Auburger G: Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiol Dis. 2007, 25: 401-411. 10.1016/j.nbd.2006.10.007.PubMed
122.
go back to reference Wood-Kaczmar A, Gandhi S, Yao Z, Abramov AS, Miljan EA, Keen G, Stanyer L, Hargreaves I, Klupsch K, Deas E, Downward J, Mansfield L, Jat P, Taylor J, Heales S, Duchen MR, Latchman D, Tabrizi SJ, Wood NW: PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS ONE. 2008, 3: e2455-10.1371/journal.pone.0002455.PubMedCentralPubMed Wood-Kaczmar A, Gandhi S, Yao Z, Abramov AS, Miljan EA, Keen G, Stanyer L, Hargreaves I, Klupsch K, Deas E, Downward J, Mansfield L, Jat P, Taylor J, Heales S, Duchen MR, Latchman D, Tabrizi SJ, Wood NW: PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS ONE. 2008, 3: e2455-10.1371/journal.pone.0002455.PubMedCentralPubMed
123.
go back to reference Deng H, Jankovic J, Guo Y, Xie W, Le W: Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem Biophys Res Commun. 2005, 337: 1133-1138. 10.1016/j.bbrc.2005.09.178.PubMed Deng H, Jankovic J, Guo Y, Xie W, Le W: Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem Biophys Res Commun. 2005, 337: 1133-1138. 10.1016/j.bbrc.2005.09.178.PubMed
124.
go back to reference Tang B, Xiong H, Sun P, Zhang Y, Wang D, Hu Z, Zhu Z, Ma H, Pan Q, Xia JH, Xia K, Zhang Z: Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease. Hum Mol Genet. 2006, 15: 1816-1825. 10.1093/hmg/ddl104.PubMed Tang B, Xiong H, Sun P, Zhang Y, Wang D, Hu Z, Zhu Z, Ma H, Pan Q, Xia JH, Xia K, Zhang Z: Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease. Hum Mol Genet. 2006, 15: 1816-1825. 10.1093/hmg/ddl104.PubMed
125.
go back to reference Pridgeon JW, Olzmann JA, Chin LS, Li L: PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1. PLoS biology. 2007, 5: e172-10.1371/journal.pbio.0050172.PubMedCentralPubMed Pridgeon JW, Olzmann JA, Chin LS, Li L: PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1. PLoS biology. 2007, 5: e172-10.1371/journal.pbio.0050172.PubMedCentralPubMed
126.
go back to reference Wang HL, Chou AH, Yeh TH, Li AH, Chen YL, Kuo YL, Tsai SR, Yu ST: PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c. Neurobiol Dis. 2007, 28: 216-226. 10.1016/j.nbd.2007.07.010.PubMed Wang HL, Chou AH, Yeh TH, Li AH, Chen YL, Kuo YL, Tsai SR, Yu ST: PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c. Neurobiol Dis. 2007, 28: 216-226. 10.1016/j.nbd.2007.07.010.PubMed
127.
go back to reference Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, Bae E, Kim J, Shong M, Kim JM, Chung J: Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature. 2006, 441: 1157-1161. 10.1038/nature04788.PubMed Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, Bae E, Kim J, Shong M, Kim JM, Chung J: Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature. 2006, 441: 1157-1161. 10.1038/nature04788.PubMed
128.
go back to reference Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, Wang JW, Yang L, Beal MF, Vogel H, Lu B: Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci USA. 2006, 103: 10793-10798. 10.1073/pnas.0602493103.PubMedCentralPubMed Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, Wang JW, Yang L, Beal MF, Vogel H, Lu B: Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci USA. 2006, 103: 10793-10798. 10.1073/pnas.0602493103.PubMedCentralPubMed
129.
go back to reference Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M: Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature. 2006, 441: 1162-1166. 10.1038/nature04779.PubMed Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M: Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature. 2006, 441: 1162-1166. 10.1038/nature04779.PubMed
130.
go back to reference Wang D, Qian L, Xiong H, Liu J, Neckameyer WS, Oldham S, Xia K, Wang J, Bodmer R, Zhang Z: Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc Natl Acad Sci USA. 2006, 103: 13520-13525. 10.1073/pnas.0604661103.PubMedCentralPubMed Wang D, Qian L, Xiong H, Liu J, Neckameyer WS, Oldham S, Xia K, Wang J, Bodmer R, Zhang Z: Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila. Proc Natl Acad Sci USA. 2006, 103: 13520-13525. 10.1073/pnas.0604661103.PubMedCentralPubMed
131.
go back to reference Kitada T, Pisani A, Porter DR, Yamaguchi H, Tscherter A, Martella G, Bonsi P, Zhang C, Pothos EN, Shen J: Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci USA. 2007, 104: 11441-11446. 10.1073/pnas.0702717104.PubMedCentralPubMed Kitada T, Pisani A, Porter DR, Yamaguchi H, Tscherter A, Martella G, Bonsi P, Zhang C, Pothos EN, Shen J: Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc Natl Acad Sci USA. 2007, 104: 11441-11446. 10.1073/pnas.0702717104.PubMedCentralPubMed
132.
go back to reference Gautier CA, Kitada T, Shen J: Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci USA. 2008, 105: 11364-11369. 10.1073/pnas.0802076105.PubMedCentralPubMed Gautier CA, Kitada T, Shen J: Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci USA. 2008, 105: 11364-11369. 10.1073/pnas.0802076105.PubMedCentralPubMed
133.
go back to reference Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998, 392: 605-608. 10.1038/33416.PubMed Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N: Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998, 392: 605-608. 10.1038/33416.PubMed
134.
go back to reference Shimura H, Hattori N, Kubo S-i, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T: Familial Parkinson disease gene product parkin is a ubiquitin-protein ligase. Nat Genet. 2000, 25: 302-305. 10.1038/77060.PubMed Shimura H, Hattori N, Kubo S-i, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T: Familial Parkinson disease gene product parkin is a ubiquitin-protein ligase. Nat Genet. 2000, 25: 302-305. 10.1038/77060.PubMed
135.
go back to reference Zhang Y, Gao J, Chung KKK, Huang H, Dawson VL, Dawson TM: Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein CDCrel-1. Proc Natl Acad Sci USA. 2000, 97: 13354-13359. 10.1073/pnas.240347797.PubMedCentralPubMed Zhang Y, Gao J, Chung KKK, Huang H, Dawson VL, Dawson TM: Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein CDCrel-1. Proc Natl Acad Sci USA. 2000, 97: 13354-13359. 10.1073/pnas.240347797.PubMedCentralPubMed
136.
go back to reference Kuroda Y, Mitsui T, Kunishige M, Shono M, Akaike M, Azuma H, Matsumoto T: Parkin enhances mitochondrial biogenesis in proliferating cells. Hum Mol Genet. 2006, 15: 883-895. 10.1093/hmg/ddl006.PubMed Kuroda Y, Mitsui T, Kunishige M, Shono M, Akaike M, Azuma H, Matsumoto T: Parkin enhances mitochondrial biogenesis in proliferating cells. Hum Mol Genet. 2006, 15: 883-895. 10.1093/hmg/ddl006.PubMed
137.
go back to reference Periquet M, Corti O, Jacquier S, Brice A: Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. J Neurochem. 2005, 95: 1259-1276. 10.1111/j.1471-4159.2005.03442.x.PubMed Periquet M, Corti O, Jacquier S, Brice A: Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. J Neurochem. 2005, 95: 1259-1276. 10.1111/j.1471-4159.2005.03442.x.PubMed
138.
go back to reference Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J: Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem. 2004, 279: 18614-18622. 10.1074/jbc.M401135200.PubMed Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, Klose J, Shen J: Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem. 2004, 279: 18614-18622. 10.1074/jbc.M401135200.PubMed
139.
go back to reference Greene JC, Whitworth AJ, Andrews LA, Parker TJ, Pallanck LJ: Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis. Hum Mol Genet. 2005, 14: 799-811. 10.1093/hmg/ddi074.PubMed Greene JC, Whitworth AJ, Andrews LA, Parker TJ, Pallanck LJ: Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis. Hum Mol Genet. 2005, 14: 799-811. 10.1093/hmg/ddi074.PubMed
140.
go back to reference Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ: Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA. 2003, 100: 4078-4083. 10.1073/pnas.0737556100.PubMedCentralPubMed Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ: Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci USA. 2003, 100: 4078-4083. 10.1073/pnas.0737556100.PubMedCentralPubMed
141.
go back to reference Pesah Y, Pham T, Burgess H, Middlebrooks B, Verstreken P, Zhou Y, Harding M, Bellen H, Mardon G: Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development. 2004, 131: 2183-2194. 10.1242/dev.01095.PubMed Pesah Y, Pham T, Burgess H, Middlebrooks B, Verstreken P, Zhou Y, Harding M, Bellen H, Mardon G: Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development. 2004, 131: 2183-2194. 10.1242/dev.01095.PubMed
142.
go back to reference Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni EG, Wu N, Ackerson LC, Klapstein GJ, Gajendiran M, Roth BL, Chesselet MF, Maidment NT, Levine MS, Shen J: Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem. 2003, 278: 43628-43635. 10.1074/jbc.M308947200.PubMed Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni EG, Wu N, Ackerson LC, Klapstein GJ, Gajendiran M, Roth BL, Chesselet MF, Maidment NT, Levine MS, Shen J: Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem. 2003, 278: 43628-43635. 10.1074/jbc.M308947200.PubMed
143.
go back to reference Darios F, Corti O, Lucking CB, Hampe C, Muriel MP, Abbas N, Gu WJ, Hirsch EC, Rooney T, Ruberg M, Brice A: Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet. 2003, 12: 517-526. 10.1093/hmg/ddg044.PubMed Darios F, Corti O, Lucking CB, Hampe C, Muriel MP, Abbas N, Gu WJ, Hirsch EC, Rooney T, Ruberg M, Brice A: Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet. 2003, 12: 517-526. 10.1093/hmg/ddg044.PubMed
144.
go back to reference Jiang H, Ren Y, Zhao J, Feng J: Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum Mol Genet. 2004, 13: 1745-1754. 10.1093/hmg/ddh180.PubMed Jiang H, Ren Y, Zhao J, Feng J: Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum Mol Genet. 2004, 13: 1745-1754. 10.1093/hmg/ddh180.PubMed
145.
go back to reference Imai Y, Soda M, Takahashi R: Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity. J Biol Chem. 2000, 275: 35661-35664. 10.1074/jbc.C000447200.PubMed Imai Y, Soda M, Takahashi R: Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity. J Biol Chem. 2000, 275: 35661-35664. 10.1074/jbc.C000447200.PubMed
146.
go back to reference Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, Vink L, Choi P, Wolozin B, Farrer M, Hardy J, Cookson MR: Parkin Protects against the Toxicity Associated with Mutant [alpha]-Synuclein: Proteasome Dysfunction Selectively Affects Catecholaminergic Neurons. Neuron. 2002, 36: 1007-1019. 10.1016/S0896-6273(02)01125-X.PubMed Petrucelli L, O'Farrell C, Lockhart PJ, Baptista M, Kehoe K, Vink L, Choi P, Wolozin B, Farrer M, Hardy J, Cookson MR: Parkin Protects against the Toxicity Associated with Mutant [alpha]-Synuclein: Proteasome Dysfunction Selectively Affects Catecholaminergic Neurons. Neuron. 2002, 36: 1007-1019. 10.1016/S0896-6273(02)01125-X.PubMed
147.
go back to reference Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC, Marsh L, Dawson VL, Dawson TM: S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science. 2004, 304: 1328-1331. 10.1126/science.1093891.PubMed Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC, Marsh L, Dawson VL, Dawson TM: S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science. 2004, 304: 1328-1331. 10.1126/science.1093891.PubMed
148.
go back to reference Yao D, Gu Z, Nakamura T, Shi Z-Q, Ma Y, Gaston B, Palmer LA, Rockenstein EM, Zhang Z, Masliah E, Uehara T, Lipton SA: Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci USA. 2004, 101: 10810-10814. 10.1073/pnas.0404161101.PubMedCentralPubMed Yao D, Gu Z, Nakamura T, Shi Z-Q, Ma Y, Gaston B, Palmer LA, Rockenstein EM, Zhang Z, Masliah E, Uehara T, Lipton SA: Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci USA. 2004, 101: 10810-10814. 10.1073/pnas.0404161101.PubMedCentralPubMed
149.
go back to reference Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA: S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature. 2006, 441: 513-517. 10.1038/nature04782.PubMed Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, Lipton SA: S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature. 2006, 441: 513-517. 10.1038/nature04782.PubMed
150.
go back to reference Moore DJ, Zhang L, Troncoso J, Lee MK, Hattori N, Mizuno Y, Dawson TM, Dawson VL: Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum Mol Genet. 2005, 14: 71-84. 10.1093/hmg/ddi007.PubMed Moore DJ, Zhang L, Troncoso J, Lee MK, Hattori N, Mizuno Y, Dawson TM, Dawson VL: Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum Mol Genet. 2005, 14: 71-84. 10.1093/hmg/ddi007.PubMed
151.
go back to reference Galter D, Westerlund M, Carmine A, Lindqvist E, Sydow O, Olson L: LRRK2 expression linked to dopamine-innervated areas. Ann Neurol. 2006, 59: 714-719. 10.1002/ana.20808.PubMed Galter D, Westerlund M, Carmine A, Lindqvist E, Sydow O, Olson L: LRRK2 expression linked to dopamine-innervated areas. Ann Neurol. 2006, 59: 714-719. 10.1002/ana.20808.PubMed
152.
go back to reference Higashi S, Moore DJ, Colebrooke RE, Biskup S, Dawson VL, Arai H, Dawson TM, Emson PC: Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain. J Neurochem. 2007, 100: 368-381. 10.1111/j.1471-4159.2006.04246.x.PubMed Higashi S, Moore DJ, Colebrooke RE, Biskup S, Dawson VL, Arai H, Dawson TM, Emson PC: Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain. J Neurochem. 2007, 100: 368-381. 10.1111/j.1471-4159.2006.04246.x.PubMed
153.
go back to reference Higashi S, Biskup S, West AB, Trinkaus D, Dawson VL, Faull RLM, Waldvogel HJ, Arai H, Dawson TM, Moore DJ, Emson PC: Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain. Brain Res. 2007, 1155: 208-219. 10.1016/j.brainres.2007.04.034.PubMed Higashi S, Biskup S, West AB, Trinkaus D, Dawson VL, Faull RLM, Waldvogel HJ, Arai H, Dawson TM, Moore DJ, Emson PC: Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain. Brain Res. 2007, 1155: 208-219. 10.1016/j.brainres.2007.04.034.PubMed
154.
go back to reference Biskup S, Moore DJ, Celsi F, Higashi S, West AB, Andrabi SA, Kurkinen K, Yu S-W, Savitt JM, Waldvogel HJ, Faull RLM, Emson PC, Torp R, Ottersen OP, Dawson TM, Dawson VL: Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol. 2006, 60: 557-569. 10.1002/ana.21019.PubMed Biskup S, Moore DJ, Celsi F, Higashi S, West AB, Andrabi SA, Kurkinen K, Yu S-W, Savitt JM, Waldvogel HJ, Faull RLM, Emson PC, Torp R, Ottersen OP, Dawson TM, Dawson VL: Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol. 2006, 60: 557-569. 10.1002/ana.21019.PubMed
155.
go back to reference West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, Dawson VL, Dawson TM: Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA. 2005, 102: 16842-16847. 10.1073/pnas.0507360102.PubMedCentralPubMed West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, Dawson VL, Dawson TM: Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA. 2005, 102: 16842-16847. 10.1073/pnas.0507360102.PubMedCentralPubMed
156.
go back to reference Hatano T, Kubo S-i, Imai S, Maeda M, Ishikawa K, Mizuno Y, Hattori N: Leucine-rich repeat kinase 2 associates with lipid rafts. Hum Mol Genet. 2007, 16: 678-690. 10.1093/hmg/ddm013.PubMed Hatano T, Kubo S-i, Imai S, Maeda M, Ishikawa K, Mizuno Y, Hattori N: Leucine-rich repeat kinase 2 associates with lipid rafts. Hum Mol Genet. 2007, 16: 678-690. 10.1093/hmg/ddm013.PubMed
157.
go back to reference MacLeod D, Dowman J, Hammond R, Leete T, Inoue K, Abeliovich A: The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron. 2006, 52: 587-593. 10.1016/j.neuron.2006.10.008.PubMed MacLeod D, Dowman J, Hammond R, Leete T, Inoue K, Abeliovich A: The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron. 2006, 52: 587-593. 10.1016/j.neuron.2006.10.008.PubMed
158.
go back to reference Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A, Brug van der MP, Beilina A, Blackinton J, Thomas KJ, Ahmad R, Miller DW, Kesavapany S, Singleton A, Lees A, Harvey RJ, Harvey K, Cookson MR: Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis. 2006, 23: 329-341. 10.1016/j.nbd.2006.04.001.PubMed Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A, Brug van der MP, Beilina A, Blackinton J, Thomas KJ, Ahmad R, Miller DW, Kesavapany S, Singleton A, Lees A, Harvey RJ, Harvey K, Cookson MR: Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis. 2006, 23: 329-341. 10.1016/j.nbd.2006.04.001.PubMed
159.
go back to reference Smith WW, Pei Z, Jiang H, Moore DJ, Liang Y, West AB, Dawson VL, Dawson TM, Ross CA: Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc Natl Acad Sci USA. 2005, 102: 18676-18681. 10.1073/pnas.0508052102.PubMedCentralPubMed Smith WW, Pei Z, Jiang H, Moore DJ, Liang Y, West AB, Dawson VL, Dawson TM, Ross CA: Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc Natl Acad Sci USA. 2005, 102: 18676-18681. 10.1073/pnas.0508052102.PubMedCentralPubMed
160.
go back to reference Tan EK, Zhao Y, Skipper L, Tan MG, Di Fonzo A, Sun L, Fook-Chong S, Tang S, Chua E, Yuen Y, Tan L, Pavanni R, Wong MC, Kolatkar P, Lu CS, Bonifati V, Liu JJ: The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum Genet. 2007, 120: 857-863. 10.1007/s00439-006-0268-0.PubMed Tan EK, Zhao Y, Skipper L, Tan MG, Di Fonzo A, Sun L, Fook-Chong S, Tang S, Chua E, Yuen Y, Tan L, Pavanni R, Wong MC, Kolatkar P, Lu CS, Bonifati V, Liu JJ: The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum Genet. 2007, 120: 857-863. 10.1007/s00439-006-0268-0.PubMed
161.
go back to reference Liou AK, Leak RK, Li L, Zigmond MJ: Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway. Neurobiol Dis. 2008, 32: 116-124. 10.1016/j.nbd.2008.06.016.PubMedCentralPubMed Liou AK, Leak RK, Li L, Zigmond MJ: Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway. Neurobiol Dis. 2008, 32: 116-124. 10.1016/j.nbd.2008.06.016.PubMedCentralPubMed
162.
go back to reference Imai Y, Gehrke S, Wang HQ, Takahashi R, Hasegawa K, Oota E, Lu B: Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J. 2008, 27: 2432-2443. 10.1038/emboj.2008.163.PubMedCentralPubMed Imai Y, Gehrke S, Wang HQ, Takahashi R, Hasegawa K, Oota E, Lu B: Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J. 2008, 27: 2432-2443. 10.1038/emboj.2008.163.PubMedCentralPubMed
163.
go back to reference Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M: Alpha-synuclein in Lewy bodies. Nature. 1997, 388: 839-840. 10.1038/42166.PubMed Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M: Alpha-synuclein in Lewy bodies. Nature. 1997, 388: 839-840. 10.1038/42166.PubMed
164.
go back to reference Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997, 276: 2045-2047. 10.1126/science.276.5321.2045.PubMed Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997, 276: 2045-2047. 10.1126/science.276.5321.2045.PubMed
165.
go back to reference Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O: Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet. 1998, 18: 106-108. 10.1038/ng0298-106.PubMed Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O: Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet. 1998, 18: 106-108. 10.1038/ng0298-106.PubMed
166.
go back to reference Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG: The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004, 55: 164-173. 10.1002/ana.10795.PubMed Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG: The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004, 55: 164-173. 10.1002/ana.10795.PubMed
167.
go back to reference Chartier-Harlin M-C, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, DestÈe A: [alpha]-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet. 2004, 364: 1167-1169. 10.1016/S0140-6736(04)17103-1.PubMed Chartier-Harlin M-C, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, DestÈe A: [alpha]-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet. 2004, 364: 1167-1169. 10.1016/S0140-6736(04)17103-1.PubMed
168.
go back to reference Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, Rohan de Silva HA, Kittel A, Saitoh T: The precursor protein of non-A[beta] component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 1995, 14: 467-475. 10.1016/0896-6273(95)90302-X.PubMed Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, Rohan de Silva HA, Kittel A, Saitoh T: The precursor protein of non-A[beta] component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 1995, 14: 467-475. 10.1016/0896-6273(95)90302-X.PubMed
169.
go back to reference Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC: Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell. 2005, 123: 383-396. 10.1016/j.cell.2005.09.028.PubMed Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC: Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell. 2005, 123: 383-396. 10.1016/j.cell.2005.09.028.PubMed
170.
go back to reference Maroteaux L, Campanelli JT, Scheller RH: Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci. 1988, 8 (8): 2804-2815.PubMed Maroteaux L, Campanelli JT, Scheller RH: Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci. 1988, 8 (8): 2804-2815.PubMed
171.
go back to reference Giasson BI, Murray IV, Trojanowski JQ, Lee VM: A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem. 2001, 276: 2380-2386. 10.1074/jbc.M008919200.PubMed Giasson BI, Murray IV, Trojanowski JQ, Lee VM: A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem. 2001, 276: 2380-2386. 10.1074/jbc.M008919200.PubMed
172.
go back to reference Conway KA, Lee S-J, Rochet J-C, Ding TT, Williamson RE, Lansbury PT: Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proc Natl Acad Sci USA. 2000, 97: 571-576. 10.1073/pnas.97.2.571.PubMedCentralPubMed Conway KA, Lee S-J, Rochet J-C, Ding TT, Williamson RE, Lansbury PT: Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proc Natl Acad Sci USA. 2000, 97: 571-576. 10.1073/pnas.97.2.571.PubMedCentralPubMed
173.
go back to reference Goldberg MS, Lansbury PT: Is there a cause-and-effect relationship between [alpha]-synuclein fibrillization and Parkinson/'s disease?. Nat Cell Biol. 2000, 2: E115-E119. 10.1038/35041081.PubMed Goldberg MS, Lansbury PT: Is there a cause-and-effect relationship between [alpha]-synuclein fibrillization and Parkinson/'s disease?. Nat Cell Biol. 2000, 2: E115-E119. 10.1038/35041081.PubMed
174.
go back to reference Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, Masliah E: Alpha-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress. Am J Pathol. 2000, 157 (2): 401-410.PubMedCentralPubMed Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M, Wong J, Takenouchi T, Hashimoto M, Masliah E: Alpha-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress. Am J Pathol. 2000, 157 (2): 401-410.PubMedCentralPubMed
175.
go back to reference Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, Jenkins NA, Price DL, Lee MK: Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci. 2006, 26: 41-50. 10.1523/JNEUROSCI.4308-05.2006.PubMed Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, Jenkins NA, Price DL, Lee MK: Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci. 2006, 26: 41-50. 10.1523/JNEUROSCI.4308-05.2006.PubMed
176.
go back to reference Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E: Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol. 2004, 186: 158-172. 10.1016/S0014-4886(03)00342-X.PubMed Song DD, Shults CW, Sisk A, Rockenstein E, Masliah E: Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol. 2004, 186: 158-172. 10.1016/S0014-4886(03)00342-X.PubMed
177.
go back to reference Nieto M, Gil-Bea FJ, Dalfo E, Cuadrado M, Cabodevilla F, Sanchez B, Catena S, Sesma T, Ribe E, Ferrer I, RamÌrez MJ, Gomez-Isla T: Increased sensitivity to MPTP in human [alpha]-synuclein A30P transgenic mice. Neurobiol Aging. 2006, 27: 848-856. 10.1016/j.neurobiolaging.2005.04.010.PubMed Nieto M, Gil-Bea FJ, Dalfo E, Cuadrado M, Cabodevilla F, Sanchez B, Catena S, Sesma T, Ribe E, Ferrer I, RamÌrez MJ, Gomez-Isla T: Increased sensitivity to MPTP in human [alpha]-synuclein A30P transgenic mice. Neurobiol Aging. 2006, 27: 848-856. 10.1016/j.neurobiolaging.2005.04.010.PubMed
178.
go back to reference Yu W, Matsuoka Y, Sziráki I, Hashim A, LaFrancois J, Sershen H, Duff K: Increased Dopaminergic Neuron Sensitivity to 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) in Transgenic Mice Expressing Mutant A53T α-Synuclein. Neurochem Res. 2008, 33: 902-911. 10.1007/s11064-007-9533-4.PubMed Yu W, Matsuoka Y, Sziráki I, Hashim A, LaFrancois J, Sershen H, Duff K: Increased Dopaminergic Neuron Sensitivity to 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) in Transgenic Mice Expressing Mutant A53T α-Synuclein. Neurochem Res. 2008, 33: 902-911. 10.1007/s11064-007-9533-4.PubMed
179.
go back to reference Norris EH, Uryu K, Leight S, Giasson BI, Trojanowski JQ, Lee VM: Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model. Am J Pathol. 2007, 170: 658-666. 10.2353/ajpath.2007.060359.PubMedCentralPubMed Norris EH, Uryu K, Leight S, Giasson BI, Trojanowski JQ, Lee VM: Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model. Am J Pathol. 2007, 170: 658-666. 10.2353/ajpath.2007.060359.PubMedCentralPubMed
180.
go back to reference Dauer W, Kholodilov N, Vila M, Trillat A-C, Goodchild R, Larsen KE, Staal R, Tieu K, Schmitz Y, Yuan CA, Rocha M, Jackson-Lewis V, Hersch S, Sulzer D, Przedborski S, Burke R, Hen R: Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci USA. 2002, 99: 14524-14529. 10.1073/pnas.172514599.PubMedCentralPubMed Dauer W, Kholodilov N, Vila M, Trillat A-C, Goodchild R, Larsen KE, Staal R, Tieu K, Schmitz Y, Yuan CA, Rocha M, Jackson-Lewis V, Hersch S, Sulzer D, Przedborski S, Burke R, Hen R: Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci USA. 2002, 99: 14524-14529. 10.1073/pnas.172514599.PubMedCentralPubMed
181.
go back to reference Klivenyi P, Siwek D, Gardian G, Yang L, Starkov A, Cleren C, Ferrante RJ, Kowall NW, Abeliovich A, Beal MF: Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol Dis. 2006, 21: 541-548. 10.1016/j.nbd.2005.08.018.PubMed Klivenyi P, Siwek D, Gardian G, Yang L, Starkov A, Cleren C, Ferrante RJ, Kowall NW, Abeliovich A, Beal MF: Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol Dis. 2006, 21: 541-548. 10.1016/j.nbd.2005.08.018.PubMed
182.
go back to reference Drolet RE, Behrouz B, Lookingland KJ, Goudreau JL: Mice Lacking [alpha]-Synuclein have an Attenuated Loss of Striatal Dopamine Following Prolonged Chronic MPTP Administration. Neurotoxicology. 2004, 25 (5): 761-769. 10.1016/j.neuro.2004.05.002.PubMed Drolet RE, Behrouz B, Lookingland KJ, Goudreau JL: Mice Lacking [alpha]-Synuclein have an Attenuated Loss of Striatal Dopamine Following Prolonged Chronic MPTP Administration. Neurotoxicology. 2004, 25 (5): 761-769. 10.1016/j.neuro.2004.05.002.PubMed
183.
go back to reference Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK: Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem. 2008, 283: 9089-9100. 10.1074/jbc.M710012200.PubMedCentralPubMed Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK: Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem. 2008, 283: 9089-9100. 10.1074/jbc.M710012200.PubMedCentralPubMed
184.
go back to reference Snyder H, Mensah K, Theisler C, Lee J, Matouschek A, Wolozin B: Aggregated and Monomeric alpha -Synuclein Bind to the S6' Proteasomal Protein and Inhibit Proteasomal Function. J Biol Chem. 2003, 278: 11753-11759. 10.1074/jbc.M208641200.PubMed Snyder H, Mensah K, Theisler C, Lee J, Matouschek A, Wolozin B: Aggregated and Monomeric alpha -Synuclein Bind to the S6' Proteasomal Protein and Inhibit Proteasomal Function. J Biol Chem. 2003, 278: 11753-11759. 10.1074/jbc.M208641200.PubMed
185.
go back to reference Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA: Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci. 2001, 21: 9549-9560.PubMed Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA: Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci. 2001, 21: 9549-9560.PubMed
186.
go back to reference Tanaka Y, Engelender S, Igarashi S, Rao RK, Wanner T, Tanzi RE, Sawa AL, Dawson V, Dawson TM, Ross CA: Inducible expression of mutant {alpha}-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet. 2001, 10: 919-926. 10.1093/hmg/10.9.919.PubMed Tanaka Y, Engelender S, Igarashi S, Rao RK, Wanner T, Tanzi RE, Sawa AL, Dawson V, Dawson TM, Ross CA: Inducible expression of mutant {alpha}-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet. 2001, 10: 919-926. 10.1093/hmg/10.9.919.PubMed
187.
go back to reference Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D: Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004, 305: 1292-1295. 10.1126/science.1101738.PubMed Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D: Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004, 305: 1292-1295. 10.1126/science.1101738.PubMed
188.
go back to reference Yang Q, She H, Gearing M, Colla E, Lee M, Shacka JJ, Mao Z: Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy. Science. 2009, 323: 124-127. 10.1126/science.1166088.PubMedCentralPubMed Yang Q, She H, Gearing M, Colla E, Lee M, Shacka JJ, Mao Z: Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy. Science. 2009, 323: 124-127. 10.1126/science.1166088.PubMedCentralPubMed
189.
go back to reference Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM: Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000, 290: 985-989. 10.1126/science.290.5493.985.PubMed Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM: Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000, 290: 985-989. 10.1126/science.290.5493.985.PubMed
190.
go back to reference Gomez-Santos C, Ferrer I, Reiriz J, Vinals F, Barrachina M, Ambrosio S: MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res. 2002, 935: 32-39. 10.1016/S0006-8993(02)02422-8.PubMed Gomez-Santos C, Ferrer I, Reiriz J, Vinals F, Barrachina M, Ambrosio S: MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res. 2002, 935: 32-39. 10.1016/S0006-8993(02)02422-8.PubMed
191.
go back to reference Sherer TB, Betarbet R, Stout AK, Lund S, Baptista M, Panov AV, Cookson MR, Greenamyre JT: An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J Neurosci. 2002, 22 (16): 7006-7015.PubMed Sherer TB, Betarbet R, Stout AK, Lund S, Baptista M, Panov AV, Cookson MR, Greenamyre JT: An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J Neurosci. 2002, 22 (16): 7006-7015.PubMed
192.
go back to reference Paxinou E, Chen Q, Weisse M, Giasson BI, Norris EH, Rueter SM, Trojanowski JQ, Lee VMY, Ischiropoulos H: Induction of {alpha}-Synuclein Aggregation by Intracellular Nitrative Insult. J Neurosci. 2001, 21 (20): 8053-8061.PubMed Paxinou E, Chen Q, Weisse M, Giasson BI, Norris EH, Rueter SM, Trojanowski JQ, Lee VMY, Ischiropoulos H: Induction of {alpha}-Synuclein Aggregation by Intracellular Nitrative Insult. J Neurosci. 2001, 21 (20): 8053-8061.PubMed
193.
go back to reference Hodara R, Norris EH, Giasson BI, Mishizen-Eberz AJ, Lynch DR, Lee VMY, Ischiropoulos H: Functional Consequences of {alpha}-Synuclein Tyrosine Nitration: diminished binding to lipid vesicles and increased fibril formation. J Biol Chem. 2004, 279: 47746-47753. 10.1074/jbc.M408906200.PubMed Hodara R, Norris EH, Giasson BI, Mishizen-Eberz AJ, Lynch DR, Lee VMY, Ischiropoulos H: Functional Consequences of {alpha}-Synuclein Tyrosine Nitration: diminished binding to lipid vesicles and increased fibril formation. J Biol Chem. 2004, 279: 47746-47753. 10.1074/jbc.M408906200.PubMed
194.
go back to reference Krishnan S, Chi EY, Wood SJ, Kendrick BS, Li C, Garzon-Rodriguez W, Wypych J, Randolph TW, Narhi LO, Biere AL, Citron M, Carpenter JF: Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis. Biochemistry. 2003, 42: 829-837. 10.1021/bi026528t.PubMed Krishnan S, Chi EY, Wood SJ, Kendrick BS, Li C, Garzon-Rodriguez W, Wypych J, Randolph TW, Narhi LO, Biere AL, Citron M, Carpenter JF: Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis. Biochemistry. 2003, 42: 829-837. 10.1021/bi026528t.PubMed
195.
go back to reference Yamin G, Uversky VN, Fink AL: Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers. FEBS lett. 2003, 542: 147-152. 10.1016/S0014-5793(03)00367-3.PubMed Yamin G, Uversky VN, Fink AL: Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers. FEBS lett. 2003, 542: 147-152. 10.1016/S0014-5793(03)00367-3.PubMed
196.
go back to reference Souza JM, Giasson BI, Chen Q, Lee VM, Ischiropoulos H: Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem. 2000, 275: 18344-18349. 10.1074/jbc.M000206200.PubMed Souza JM, Giasson BI, Chen Q, Lee VM, Ischiropoulos H: Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem. 2000, 275: 18344-18349. 10.1074/jbc.M000206200.PubMed
197.
go back to reference Norris EH, Giasson BI, Ischiropoulos H, Lee VM: Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications. J Biol Chem. 2003, 278: 27230-27240. 10.1074/jbc.M212436200.PubMed Norris EH, Giasson BI, Ischiropoulos H, Lee VM: Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications. J Biol Chem. 2003, 278: 27230-27240. 10.1074/jbc.M212436200.PubMed
198.
go back to reference Paik SR, Shin HJ, Lee JH: Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide. Arch Biochem Biophys. 2000, 378: 269-277. 10.1006/abbi.2000.1822.PubMed Paik SR, Shin HJ, Lee JH: Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide. Arch Biochem Biophys. 2000, 378: 269-277. 10.1006/abbi.2000.1822.PubMed
199.
go back to reference Conway KA, Rochet JC, Bieganski RM, Lansbury PT: Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science. 2001, 294: 1346-1349. 10.1126/science.1063522.PubMed Conway KA, Rochet JC, Bieganski RM, Lansbury PT: Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science. 2001, 294: 1346-1349. 10.1126/science.1063522.PubMed
200.
go back to reference Norris EH, Giasson BI, Hodara R, Xu S, Trojanowski JQ, Ischiropoulos H, Lee VM: Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations. J Biol Chem. 2005, 280: 21212-21219. 10.1074/jbc.M412621200.PubMed Norris EH, Giasson BI, Hodara R, Xu S, Trojanowski JQ, Ischiropoulos H, Lee VM: Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations. J Biol Chem. 2005, 280: 21212-21219. 10.1074/jbc.M412621200.PubMed
201.
go back to reference Mazzulli JR, Armakola M, Dumoulin M, Parastatidis I, Ischiropoulos H: Cellular Oligomerization of {alpha}-Synuclein Is Determined by the Interaction of Oxidized Catechols with a C-terminal Sequence. J Biol Chem. 2007, 282: 31621-31630. 10.1074/jbc.M704737200.PubMed Mazzulli JR, Armakola M, Dumoulin M, Parastatidis I, Ischiropoulos H: Cellular Oligomerization of {alpha}-Synuclein Is Determined by the Interaction of Oxidized Catechols with a C-terminal Sequence. J Biol Chem. 2007, 282: 31621-31630. 10.1074/jbc.M704737200.PubMed
202.
go back to reference Herrera FE, Chesi A, Paleologou KE, Schmid A, Munoz A, Vendruscolo M, Gustincich S, Lashuel HA, Carloni P: Inhibition of alpha-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region. PLoS ONE. 2008, 3: e3394-10.1371/journal.pone.0003394.PubMedCentralPubMed Herrera FE, Chesi A, Paleologou KE, Schmid A, Munoz A, Vendruscolo M, Gustincich S, Lashuel HA, Carloni P: Inhibition of alpha-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region. PLoS ONE. 2008, 3: e3394-10.1371/journal.pone.0003394.PubMedCentralPubMed
203.
go back to reference Mazzulli JR, Mishizen AJ, Giasson BI, Lynch DR, Thomas SA, Nakashima A, Nagatsu T, Ota A, Ischiropoulos H: Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. J Neurosci. 2006, 26: 10068-10078. 10.1523/JNEUROSCI.0896-06.2006.PubMed Mazzulli JR, Mishizen AJ, Giasson BI, Lynch DR, Thomas SA, Nakashima A, Nagatsu T, Ota A, Ischiropoulos H: Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. J Neurosci. 2006, 26: 10068-10078. 10.1523/JNEUROSCI.0896-06.2006.PubMed
204.
go back to reference Nagatsu T: Change of tyrosine hydroxylase in the parkinsonian brain and in the brain of MPTP-treated mice as revealed by homospecific activity. Neurochem Res. 1990, 15: 425-429. 10.1007/BF00969928.PubMed Nagatsu T: Change of tyrosine hydroxylase in the parkinsonian brain and in the brain of MPTP-treated mice as revealed by homospecific activity. Neurochem Res. 1990, 15: 425-429. 10.1007/BF00969928.PubMed
205.
go back to reference Grune T, Shringarpure R, Sitte N, Davies K: Age-related changes in protein oxidation and proteolysis in mammalian cells. J Gerontol A Biol Sci Med Sci. 2001, 56 (11): B459-B467.PubMed Grune T, Shringarpure R, Sitte N, Davies K: Age-related changes in protein oxidation and proteolysis in mammalian cells. J Gerontol A Biol Sci Med Sci. 2001, 56 (11): B459-B467.PubMed
206.
go back to reference Stadtman ER, Levine RL: Protein oxidation. Ann N Y Acad Sci. 2000, 899: 191-208.PubMed Stadtman ER, Levine RL: Protein oxidation. Ann N Y Acad Sci. 2000, 899: 191-208.PubMed
207.
go back to reference Oliver CN, Ahn BW, Moerman EJ, Goldstein S, Stadtman ER: Age-related changes in oxidized proteins. J Biol Chem. 1987, 262: 5488-5491.PubMed Oliver CN, Ahn BW, Moerman EJ, Goldstein S, Stadtman ER: Age-related changes in oxidized proteins. J Biol Chem. 1987, 262: 5488-5491.PubMed
208.
go back to reference Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR: Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA. 1991, 88: 10540-10543. 10.1073/pnas.88.23.10540.PubMedCentralPubMed Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR: Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA. 1991, 88: 10540-10543. 10.1073/pnas.88.23.10540.PubMedCentralPubMed
209.
go back to reference Ding Q, Dimayuga E, Keller JN: Proteasome regulation of oxidative stress in aging and age-related diseases of the CNS. Antioxid Redox Signal. 2006, 8: 163-172. 10.1089/ars.2006.8.163.PubMed Ding Q, Dimayuga E, Keller JN: Proteasome regulation of oxidative stress in aging and age-related diseases of the CNS. Antioxid Redox Signal. 2006, 8: 163-172. 10.1089/ars.2006.8.163.PubMed
210.
go back to reference Farout L, Friguet B: Proteasome function in aging and oxidative stress: implications in protein maintenance failure. Antioxid Redox Signal. 2006, 8: 205-216. 10.1089/ars.2006.8.205.PubMed Farout L, Friguet B: Proteasome function in aging and oxidative stress: implications in protein maintenance failure. Antioxid Redox Signal. 2006, 8: 205-216. 10.1089/ars.2006.8.205.PubMed
211.
go back to reference Cuervo AM, Dice JF: Age-related decline in chaperone-mediated autophagy. J Biol Chem. 2000, 275: 31505-31513. 10.1074/jbc.M002102200.PubMed Cuervo AM, Dice JF: Age-related decline in chaperone-mediated autophagy. J Biol Chem. 2000, 275: 31505-31513. 10.1074/jbc.M002102200.PubMed
212.
go back to reference Donati A, Cavallini G, Paradiso C, Vittorini S, Pollera M, Gori Z, Bergamini E: Age-related changes in the regulation of autophagic proteolysis in rat isolated hepatocytes. J Gerontol A Biol Sci Med Sci. 2001, 56 (7): B288-B293.PubMed Donati A, Cavallini G, Paradiso C, Vittorini S, Pollera M, Gori Z, Bergamini E: Age-related changes in the regulation of autophagic proteolysis in rat isolated hepatocytes. J Gerontol A Biol Sci Med Sci. 2001, 56 (7): B288-B293.PubMed
213.
go back to reference Dice JF: Altered degradation of proteins microinjected into senescent human fibroblasts. J Biol Chem. 1982, 257 (24): 14624-14627.PubMed Dice JF: Altered degradation of proteins microinjected into senescent human fibroblasts. J Biol Chem. 1982, 257 (24): 14624-14627.PubMed
214.
go back to reference Martinez-Vicente M, Sovak G, Cuervo AM: Protein degradation and aging. Exp Gerontol. 2005, 40: 622-633. 10.1016/j.exger.2005.07.005.PubMed Martinez-Vicente M, Sovak G, Cuervo AM: Protein degradation and aging. Exp Gerontol. 2005, 40: 622-633. 10.1016/j.exger.2005.07.005.PubMed
215.
go back to reference Terman A: The effect of age on formation and elimination of autophagic vacuoles in mouse hepatocytes. Gerontology. 1995, 41 (Suppl 2): 319-326. 10.1159/000213753.PubMed Terman A: The effect of age on formation and elimination of autophagic vacuoles in mouse hepatocytes. Gerontology. 1995, 41 (Suppl 2): 319-326. 10.1159/000213753.PubMed
216.
go back to reference Sitte N, Merker K, Von Zglinicki T, Davies KJ, Grune T: Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part II–aging of nondividing cells. Faseb J. 2000, 14: 2503-2510. 10.1096/fj.00-0210com.PubMed Sitte N, Merker K, Von Zglinicki T, Davies KJ, Grune T: Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part II–aging of nondividing cells. Faseb J. 2000, 14: 2503-2510. 10.1096/fj.00-0210com.PubMed
217.
go back to reference Sullivan PG, Dragicevic NB, Deng JH, Bai Y, Dimayuga E, Ding Q, Chen Q, Bruce-Keller AJ, Keller JN: Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J Biol Chem. 2004, 279: 20699-20707. 10.1074/jbc.M313579200.PubMed Sullivan PG, Dragicevic NB, Deng JH, Bai Y, Dimayuga E, Ding Q, Chen Q, Bruce-Keller AJ, Keller JN: Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J Biol Chem. 2004, 279: 20699-20707. 10.1074/jbc.M313579200.PubMed
218.
go back to reference LaVoie MJ, Hastings TG: Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci. 1999, 19 (4): 1484-1491.PubMed LaVoie MJ, Hastings TG: Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci. 1999, 19 (4): 1484-1491.PubMed
219.
go back to reference LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ: Dopamine covalently modifies and functionally inactivates parkin. Nat Med. 2005, 11: 1214-1221. 10.1038/nm1314.PubMed LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ: Dopamine covalently modifies and functionally inactivates parkin. Nat Med. 2005, 11: 1214-1221. 10.1038/nm1314.PubMed
220.
go back to reference Hastings TG, Lewis DA, Zigmond MJ: Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci USA. 1996, 93: 1956-1961. 10.1073/pnas.93.5.1956.PubMedCentralPubMed Hastings TG, Lewis DA, Zigmond MJ: Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci USA. 1996, 93: 1956-1961. 10.1073/pnas.93.5.1956.PubMedCentralPubMed
221.
go back to reference Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL, Colebrooke RE, Di Monte DA, Emson PC, Miller GW: Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci. 2007, 27: 8138-8148. 10.1523/JNEUROSCI.0319-07.2007.PubMed Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL, Colebrooke RE, Di Monte DA, Emson PC, Miller GW: Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci. 2007, 27: 8138-8148. 10.1523/JNEUROSCI.0319-07.2007.PubMed
222.
go back to reference Rosenberg PA: Catecholamine toxicity in cerebral cortex in dissociated cell culture. J Neurosci. 1988, 8 (8): 2887-2894.PubMed Rosenberg PA: Catecholamine toxicity in cerebral cortex in dissociated cell culture. J Neurosci. 1988, 8 (8): 2887-2894.PubMed
223.
go back to reference Zecca L, Zucca FA, Albertini A, Rizzio E, Fariello RG: A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease. Neurology. 2006, 67 (7 Suppl 2): S8-S11.PubMed Zecca L, Zucca FA, Albertini A, Rizzio E, Fariello RG: A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease. Neurology. 2006, 67 (7 Suppl 2): S8-S11.PubMed
224.
go back to reference D'Amato RJ, Lipman ZP, Snyder SH: Selectivity of the Parkinsonian Neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin. Science. 1986, 231: 987-989. 10.1126/science.3080808.PubMed D'Amato RJ, Lipman ZP, Snyder SH: Selectivity of the Parkinsonian Neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin. Science. 1986, 231: 987-989. 10.1126/science.3080808.PubMed
225.
go back to reference Luigi Zecca Casella L, Albertini A, Bellei C, Zucca FA, Engelen M, Zadlo A, Szewczyk G, Zareba M, Sarna T: Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease. J Neurochem. 2008, 106 (4): 1866-1875.PubMed Luigi Zecca Casella L, Albertini A, Bellei C, Zucca FA, Engelen M, Zadlo A, Szewczyk G, Zareba M, Sarna T: Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease. J Neurochem. 2008, 106 (4): 1866-1875.PubMed
226.
go back to reference Faucheux BA, Martin ME, Beaumont C, Hauw JJ, Agid Y, Hirsch EC: Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease. J Neurochem. 2003, 86 (5): 1142-1148.PubMed Faucheux BA, Martin ME, Beaumont C, Hauw JJ, Agid Y, Hirsch EC: Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease. J Neurochem. 2003, 86 (5): 1142-1148.PubMed
227.
go back to reference Guelman LR, Pagotto RM, Di Toro CG, Zieher LM: Deferoxamine antioxidant activity on cerebellar granule cells [gamma]-irradiated in vitro. Neurotoxicol Teratol. 2004, 26: 477-483. 10.1016/j.ntt.2004.02.001.PubMed Guelman LR, Pagotto RM, Di Toro CG, Zieher LM: Deferoxamine antioxidant activity on cerebellar granule cells [gamma]-irradiated in vitro. Neurotoxicol Teratol. 2004, 26: 477-483. 10.1016/j.ntt.2004.02.001.PubMed
228.
go back to reference Santiago M, Matarredona ER, Granero L, Cano J: Neuroprotective Effect of the Iron Chelator Desferrioxamine Against MPP+ Toxicity on Striatal Dopaminergic Terminals. J Neurochem. 1997, 68 (2): 732-738.PubMed Santiago M, Matarredona ER, Granero L, Cano J: Neuroprotective Effect of the Iron Chelator Desferrioxamine Against MPP+ Toxicity on Striatal Dopaminergic Terminals. J Neurochem. 1997, 68 (2): 732-738.PubMed
229.
go back to reference Shachar DB, Kahana N, Kampel V, Warshawsky A, Youdim MBH: Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. Neuropharmacology. 2004, 46: 254-263. 10.1016/j.neuropharm.2003.09.005.PubMed Shachar DB, Kahana N, Kampel V, Warshawsky A, Youdim MBH: Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. Neuropharmacology. 2004, 46: 254-263. 10.1016/j.neuropharm.2003.09.005.PubMed
230.
go back to reference Ben-Shachar D, Eshel G, Finberg JP, Youdim MB: The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J Neurochem. 1991, 56: 1441-1444. 10.1111/j.1471-4159.1991.tb11444.x.PubMed Ben-Shachar D, Eshel G, Finberg JP, Youdim MB: The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J Neurochem. 1991, 56: 1441-1444. 10.1111/j.1471-4159.1991.tb11444.x.PubMed
231.
go back to reference Hirsch E, Graybiel AM: Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature. 1988, 334: 345-348. 10.1038/334345a0.PubMed Hirsch E, Graybiel AM: Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature. 1988, 334: 345-348. 10.1038/334345a0.PubMed
232.
go back to reference Fasano M, Giraudo S, Coha S, Bergamasco B, Lopiano L: Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to [alpha]-synuclein. Neurochem Int. 2003, 42: 603-606. 10.1016/S0197-0186(02)00161-4.PubMed Fasano M, Giraudo S, Coha S, Bergamasco B, Lopiano L: Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to [alpha]-synuclein. Neurochem Int. 2003, 42: 603-606. 10.1016/S0197-0186(02)00161-4.PubMed
233.
go back to reference Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL: {alpha}-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Brain. 2005, 128: 2654-2664. 10.1093/brain/awh584.PubMed Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL: {alpha}-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Brain. 2005, 128: 2654-2664. 10.1093/brain/awh584.PubMed
234.
go back to reference Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, Kelly JW: Functional Amyloid Formation within Mammalian Tissue. PLoS biology. 2006, 4: e6-10.1371/journal.pbio.0040006.PubMedCentralPubMed Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, Kelly JW: Functional Amyloid Formation within Mammalian Tissue. PLoS biology. 2006, 4: e6-10.1371/journal.pbio.0040006.PubMedCentralPubMed
235.
go back to reference Hurbain I, Geerts WJC, Boudier T, Marco S, Verkleij AJ, Marks MS, Raposo G: Electron tomography of early melanosomes: Implications for melanogenesis and the generation of fibrillar amyloid sheets. Proc Natl Acad Sci USA. 2008, 105: 19726-19731. 10.1073/pnas.0803488105.PubMedCentralPubMed Hurbain I, Geerts WJC, Boudier T, Marco S, Verkleij AJ, Marks MS, Raposo G: Electron tomography of early melanosomes: Implications for melanogenesis and the generation of fibrillar amyloid sheets. Proc Natl Acad Sci USA. 2008, 105: 19726-19731. 10.1073/pnas.0803488105.PubMedCentralPubMed
236.
go back to reference Fedorow H, Pickford R, Hook JM, Double KL, Halliday GM, Gerlach M, Riederer P, Garner B: Dolichol is the major lipid component of human substantia nigra neuromelanin. J Neurochem. 2005, 92: 990-995. 10.1111/j.1471-4159.2004.02975.x.PubMed Fedorow H, Pickford R, Hook JM, Double KL, Halliday GM, Gerlach M, Riederer P, Garner B: Dolichol is the major lipid component of human substantia nigra neuromelanin. J Neurochem. 2005, 92: 990-995. 10.1111/j.1471-4159.2004.02975.x.PubMed
238.
go back to reference Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L: Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science. 2000, 287: 1265-1269. 10.1126/science.287.5456.1265.PubMed Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L: Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science. 2000, 287: 1265-1269. 10.1126/science.287.5456.1265.PubMed
239.
go back to reference Tofaris GK, Garcia Reitbock P, Humby T, Lambourne SL, O'Connell M, Ghetti B, Gossage H, Emson PC, Wilkinson LS, Goedert M, Spillantini MG: Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1–120): implications for Lewy body disorders. J Neurosci. 2006, 26: 3942-3950. 10.1523/JNEUROSCI.4965-05.2006.PubMed Tofaris GK, Garcia Reitbock P, Humby T, Lambourne SL, O'Connell M, Ghetti B, Gossage H, Emson PC, Wilkinson LS, Goedert M, Spillantini MG: Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1–120): implications for Lewy body disorders. J Neurosci. 2006, 26: 3942-3950. 10.1523/JNEUROSCI.4965-05.2006.PubMed
240.
go back to reference Richfield EK, Thiruchelvam MJ, Cory-Slechta DA, Wuertzer C, Gainetdinov RR, Caron MG, Di Monte DA, Federoff HJ: Behavioral and Neurochemical Effects of Wild-Type and Mutated Human [alpha]-Synuclein in Transgenic Mice. Exp Neurol. 2002, 175: 35-48. 10.1006/exnr.2002.7882.PubMed Richfield EK, Thiruchelvam MJ, Cory-Slechta DA, Wuertzer C, Gainetdinov RR, Caron MG, Di Monte DA, Federoff HJ: Behavioral and Neurochemical Effects of Wild-Type and Mutated Human [alpha]-Synuclein in Transgenic Mice. Exp Neurol. 2002, 175: 35-48. 10.1006/exnr.2002.7882.PubMed
Metadata
Title
Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle
Authors
Kristen A Malkus
Elpida Tsika
Harry Ischiropoulos
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Molecular Neurodegeneration / Issue 1/2009
Electronic ISSN: 1750-1326
DOI
https://doi.org/10.1186/1750-1326-4-24

Other articles of this Issue 1/2009

Molecular Neurodegeneration 1/2009 Go to the issue